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ABSTRACT OF THE DISSERTATION
THE INFLUENCE OF THE PROXIMAL THIOLATE LIGAND AND HYDROGEN
BOND NETWORK OF THE PROXIMAL HELIX ON THE STRUCTURAL AND
BIOCHEMICAL PROPERTIES OF CHLOROPEROXIDASE
by
Elena Shersher
Florida International University, 2016
Miami, Florida
Professor Xiaotang Wang, Major Professor
Chloroperoxidase (CPO) from Caldariomyces fumago is a versatile heme enzyme
with great potential for environmental and pharmaceutical applications. It catalyzes a
plethora of reactions including halogenation, dismutation, epoxidation, and oxidation. The
diverse catalytic capabilities of CPO have long been attributed to the protein’s distinct
active site that combines structural features of peroxidases and cytochromes P450.
Particularly, the role of the axial thiolate ligand in CPO catalysis has been much debated.
Furthermore, no data are available on the role of hydrogen bonding between Arg26 –
Asn37 and Ala27 – Asn33 of the proximal helix in defining the structural and catalytic
properties of CPO.
In order to investigate the influence of the proximal thiolate and the proximal
hydrogen bond network on the structural and biochemical properties of CPO, several
mutant CPOs were constructed and characterized using various spectroscopic techniques
and enzymatic assays. Cysteine 29, which coordinates to the heme, was replaced with a
His (C29H) to mimic the proximal ligation of classical peroxidases. The UV-Vis spectrum
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of the carbon monoxide complex of ferrous C29H mutant remained essentially identical to
that of wild type (WT) CPO and P450 although the ferric state of the variant enzyme
showed a spectral pattern reminiscent of a classical histidine ligated heme peroxidase.
Histidine ligation was further confirmed by paramagnetic NMR spectroscopy. Contrary to
a previous report, the specific chlorination activity of C29H was essentially abolished (less
than 1% of that of WT CPO) but the epoxidation and peroxidation activities were enhanced
10-fold and 55-fold, respectively. These findings demonstrate for the first time that the
heme ligand, Cys29 in CPO, is not a prerequisite for CPO’s unique P450-like spectroscopic
signatures but is constitutive for the protein’s versatile catalytic activities.
Arginine 26 and Asparagine 33 in the proximal heme pocket were replaced with Ala
(R26A, N33A, and R26A/N33A) to disrupt hydrogen bonding. Tertiary structures and
heme environments of R26A, N33A, and R26A/N33A differed from those of WT CPO as
determined by CD spectroscopy. The specific chlorination and dismutation activities of all
mutants were almost abolished but the peroxidation and epoxidation rates were increased.
These results show that the proximal hydrogen bond network plays an important role in
maintaining the structure and catalytic diversity of CPO.
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CHAPTER I.
HEME PROTEIN DIVERSITY: STRUCTURE, FUNCTION, APPLICATIONS
1.1 Introduction to heme proteins
Heme proteins are ubiquitous in both eukaryotic and prokaryotic organisms. They
carry out a variety of biological functions that includes oxygen transport, electron transfer,
signal transduction (via sensing diatomic gases), and catalysis of various redox reactions
(Table 1.1).
Table 1.1. Heme proteins and their biological functions.
Function

Proteins

References

O 2 transport or

Myoglobin (Mb)

(1-3)

storage

Hemoglobin

(1-3)

Leghemoglobin

(4)

Neuroglobin

(5-6)

Cytoglobin

(7)

Electron transfer

Cytochromes a, b, and c

(8-9)

Signal transduction

Guanylate cyclase (NO, CO)

(10-12)

FixL (O 2 )

(13-15)

EcDos (O 2 , NO, CO)

(16-17)

NPAS2 (CO)

(18-19)

HemAT (O 2 )

(20)

CooA (CO)

(21-22)

Peroxidases

(23-28)

Catalases

(29-30)

NO synthase

(31)

Cytochromes P450

(32-33)

Catalysis
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Each class of heme proteins contains one or two heme moieties as the prosthetic
group. In general, the heme consists of a ferrous iron centered inside a substituted
heterocyclic porphine molecule known as porphyrin. The nature and location of the
substituents on a porphine determines the type of heme (a, b, c, d 1 , f, o). The most
frequently encountered heme groups are shown in Fig. 1.1. The majority of heme proteins
possess heme b, also known as iron protoporphyrin IX (34). Enzymes containing non-b
heme groups include cytochromes a, cytochromes c, nitrite reductases, cytochromes b6f,
and heme-copper oxidases that possess heme a, c, d 1 , f, and o, respectively (35-39).
Since iron protoporphyrin IX is the most common type of heme found in heme
proteins, the following discussion will concentrate on b-type heme proteins. The iron in
the heme group is coordinated to the four nitrogens of the porphyrin in addition to one or
two axial ligands that usually include such amino acids as histidine, cysteine, tyrosine,
methionine, or lysine (40). In many heme proteins, the heme group is located in proximity
to an alpha-helix parallel to the porphyrin plane that is responsible for heme-protein
packing interactions (41). The extent of heme exposure to solvent plays a role in
determining biochemical properties of the protein (42). In addition, the type of the heme
group together with the nature of metal ligation and the proximal and distal environment
in the active site determine the reactivity of heme enzymes and their selectivity toward
substrates (43-45).
The following two sections will describe heme proteins that carry out various catalytic
functions and utilize either hydrogen peroxide or molecular oxygen to perform a plethora
of oxidation reactions. I will concentrate my discussion on the family of enzymes called
peroxidases and, particularly, on fungal chloroperoxidase (CPO) since it is the subject of
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my research. Structural, spectroscopic, and catalytic properties of CPO will be discussed
in more detail.

Heme a

Heme b

Heme c

Heme d 1

Figure 1.1. Structures of heme groups most frequently found in heme proteins.
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1.2 Peroxidases
Classical peroxidases are enzymes capable of catalyzing one-electron oxidations of a
variety of substrates, using hydrogen peroxide as an oxidizing agent. The majority of
peroxidases contain a heme group as the co-factor; however, a few are known to utilize
other co-factors. For example, glutathione peroxidase and phospholipid hydroperoxide
glutathione peroxidase utilize selenium as a co-factor (46). Originally, peroxidases were
grouped into two major families: animal and plant peroxidases. However, over time
peroxidases were found in other organisms including bacteria, and many peroxidases were
found across different kingdoms of life. Moreover, some peroxidases were found to be able
to catalyze reactions that are usually performed by other biological catalysts such as
catalases, oxygenases, and peroxygenases. Therefore, a more appropriate classification of
peroxidases reflects the types of reactions catalyzed by a particular family. According to
this classification, heme peroxidases are grouped into 4 superfamilies: peroxidasescatalases, peroxidases-cyclooxygenases, peroxidases-peroxygenases, and CDE (chloritedismutase-DyP-EfeB) heme peroxidases (47-49). The members of each protein
superfamily are given in Table 1.2.
1.2.1

Peroxidase-catalases
Peroxidase-catalases, in addition to catalyzing classical peroxidation reactions, are

able to perform the decomposition of hydrogen peroxide, a reaction typically catalyzed by
regular catalases to protect cells from oxidative damage (30). Peroxidase-catalases are the
most diverse and abundant superfamily, and is further divided into subfamilies of Class I,
Class II, and Class III whose representatives belong to intracellular, fungal extracellular,
and plant extracellular proteins, respectively. All three classes of peroxidases-catalases
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contain conserved, catalytically important distal Arg-Trp/Phe-His and proximal HisTrp/Phe-Asp triads (Fig. 1.2 A-C) (63-66). Proximal heme ligation to a His is similar to
ligation in other peroxidase families (except peroxygenases) and in contrast to a tyrosine
proximal heme ligand in monofunctional catalases (67). The proximal His is coordinated
to the iron of the heme through Nε, and the distal His acts as the acid-base catalyst during
the formation of Compound I, which is discussed below.
Table 1.2. Classification of heme peroxidases.
Superfamily

Representative proteins

References

Catalase-peroxidases (KatGs)

(50)

Cytochrome c peroxidase (CcP)

(51)

Ascorbate peroxidase (APO)

(52)

Lignin peroxidase (LiP)

(24)

Manganese peroxidase (MnP)

(25)

Peroxidase-catalases
Class I (intracellular)

Class II (extracellular fungal)

Class III (extracellular plant) Versatile peroxidase (VPO)

(53)

(Welinder 1992)

Horseradish peroxidase (HRP)

(23)

Peroxidase-cyclooxygenases

Myeloperoxidase (MPO)

(26)

Eosinophil peroxidase (EPO)

(54)

Lactoperoxidase (LPO)

(55)

Thyroid peroxidase (TPO)

(56)

CDE superfamily

Chlorite dismutases (Clds)

(57-58)

Subfamilies:

Dye-decolorizing peroxidases (DyPs)

(59-60)

Clds, EfeB,

EfeB

(61)

Chloroperoxidase (CPO)

(32-33)

Unspecific peroxygenases (UPOs)

(62)

DyPs A, B, C, and D
Peroxidase-peroxygenases
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1.2.2 Peroxidase-cyclooxygenases
The members of the peroxidase–cyclooxygenase superfamily catalyze the
oxygenation of fatty acids in the formation of prostaglandins which are autocrine and
paracrine lipid mediators involved in pain sensitivity, fever regulation, cell growth control,
and hormonal regulation (68). The superfamily includes mammalian, plant, fungal, and
bacterial proteins. Mammalian cyclooxygenases are the most studied and include
myeloperoxidase, eosinophil peroxidase, lactoperoxidase, and thyroid peroxidase. Active
sites of mammalian cyclooxygenases possess two ester linkages between the heme group
and conserved distal aspartate and glutamate residues. Other conserved residues include
distal His and Asp together with proximal His hydrogen bonded to Asn (Fig. 1.2 D, 69).
Distal His is involved in the formation of catalytic species, Compound I, while distal
glutamine residue and several water molecules form a hydrogen-bond network involved in
halide delivery and binding (47).
1.2.3 CDE peroxidases
The CDE superfamily consists of dye decolorizing peroxidases, chlorite dismutases,
and EfeB enzymes that are found in fungal, archeal, and bacterial phyla. This superfamily
of heme enzymes has only been recently identified and only a few members have crystal
structures available that have been biochemically characterized. The active sites of known
CDE proteins possess a His-Asp/Glu pair in the proximal pocket and an Asp-Arg pair in
the distal pocket (49).
In contrast to a distal His in other peroxidases, CDE enzymes use aspartic acid in their
catalysis (70-72). The reactions that are catalyzed by this superfamily include but are not
limited to: oxidations of azo dyes such as Reactive Black 5, 2,6-dimethoxyphenol, and
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other substituted phenols, 2,20 -azino-bis(3-ethylbenzothiazoline-6-sulfonic acid (ABTS),
β-carotene, ascorbic acid, and anthraquinone dyes such as Reactive Blue 19, Reactive Blue
5 (73-79).

Figure 1.2. Active site structures of cytochrome c peroxidase from Saccharomyces
cerevisiae (A), lignin peroxidase from Phanerochaete chrysosporium (B), horseradish
peroxidase from Armoracia rusticana (C), lactoperoxidase from Bubalis bubalis (D), dye
decolorizing peroxidase from Thanatephorus cucumeris (E), and chloroperoxidase from
Calderiomyces fumago (F). The following pdb files were used to visualize the active sites:
1CCA, 1B82, 1ATJ, 2GJM, 3AFV, 1CPO (64-66, 69-71).
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1.2.4 Peroxidase-peroxygenases
Peroxidase-peroxygenases, besides catalyzing peroxidation reaction, are able to
incorporate oxygen from hydrogen peroxide into various substrates. The most studied
member of this superfamily is chloroperoxidase from the Caldariomyces fumago fungus,
which is a focus of my research and will be discussed in detail in section 1.3. Other
enzymes belonging to this group have only recently been discovered and characterized.
Examples include unspecific peroxygenases (UPOs) from the basidiomycetous fungi
Agrocybe aegerita (AaeUPO), Coprinus radians, and Marasmius rotula (80-82). These
UPOs are functional peroxygenases that transfer an oxygen atom from hydrogen peroxide
to diverse organic substrates (aromatics, heterocycles, linear and cyclic alkanes/ alkenes,
fatty acids, etc. (83-86). In addition to these reactions, UPOs are able to catalyze O- and
N-dealkylation, dechlorination, and halide oxidation (87).
A feature that distinguishes this superfamily from other heme peroxidases is the use
of a Cys residue as the proximal heme ligand instead of a His. Furthermore, active sites of
known peroxygenases and CPO share common structural motifs R(G/A)PCP(G/A)LN in
the proximal side and E(N/H)D in the distal side (Fig. 1.3). In addition, the proximal alphahelix in both CPO and AaeUPO has a similar orientation, being almost perpendicular to
the heme plane. The orientation of this alpha-helix has been suggested to fine-tune the
redox potential of the heme (88).
It has been proposed that UPOs are structural hybrids between classical peroxidases
and cytochrome P450 monooxygenases (CYPs), combining the more polar distal side of
peroxidases with the proximal thiolate ligation of CYPs (Fig. 1.3) (62). CYPs are hemethiolate proteins, whose main function is oxygen insertion into organic substrates using
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molecular oxygen and NAD(P)H (91). However, some CYPs, such as P450 SPα from
Sphingomonas paucimobilis and P450 BSβ from Bacillius subtilis, are capable of using
hydrogen peroxide or organic peroxide through the ‘peroxide-shunt’ pathway in the
absence of NAD(P)H (92-93). Peroxygenation reactions carried out by P450s are, however,
much less efficient than those performed by true peroxygenases. Since peroxygenases
combine structural features of peroxidases and CYPs, they allow for the utilization of a
catalytic cycle of classical heme peroxidases with the “peroxide shunt” of P450s in their
catalysis. Interestingly, spectral studies on CPO and AaeUPO suggest that the latter is
closer to cytochromes P450 than to CPO and may constitute a functional hybrid of the two
(94).

Figure 1.3. Active site structures of aromatic peroxygenase from A. aegerita (A),
chloroperoxidase from C. fumago (B), and cytochrome P450 3A4 from Homo sapiens (C).
The following pdb files were used to visualize the active sites: 2YOR, 1CPO, and 1W0E
(71, 89, 90). Heme is depicted in purple color and proximal axial ligands are indicated in
red. Side chains of the proximal amino acids involved in hydrogen bond network (subject
of chapters 3 and 4) formation are shown in blue.

9

1.3 Chloroperoxidase
Chloroperoxidase, produced by the ascomycetous fungus Caldariomyces fumago, is
a heme-containing protein that belongs to the peroxidase-peroxygenase family. The
biological function of this extracellular protein is proposed to be the chlorination of 2chlorocyclopentane-1,3-dione to 2,2-dichlorocyclopentane-1,3-dione, which is a precursor
of caldariomycin, a compound with antibacterial properties, thus providing the fungus with
protection against microbes (95). In addition to halogenation, CPO is able to carry out
catalysis of a plethora of oxidative reactions that are characteristic of other enzyme classes,
using hydrogen peroxide as an oxidizing agent. The catalytic diversity of CPO has been
attributed to its unique structure and will be discussed below.
1.3.1 The structure of CPO
Chloroperoxidase is a heavily glycosylated heme-containing protein with a molecular
weight of approximately 42 kilodaltons (95). It is initially synthesized as a 373-amino-acid
precursor polypeptide and then underdoes extensive post-translational modifications that
include removal of a 21-amino-acid signal peptide from the N-terminus, removal of a 53amino-acid sequence from the C-terminus that aids in correct folding, cyclization of Nterminal glutamic acid into pyroglutamic acid, N- and O-glycosylations, deamidation of
three amidic residues to their corresponding acids, a disulfide bond formation, and
incorporation of heme b (71, 96, 97). Interestingly, two isoforms of CPO were identified
depending on the glycosylation pattern, with the major one possessing 21 sugar groups
located at 3 N- and 11 O-glycosylation sites (71).
Similarly to other heme peroxidases, CPO is folded into N- and C-terminal domains
with the heme group located between the domains. The secondary structure of CPO
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includes 8 alpha helices (A-H) and one small beta pair (Fig. 1.4). However, the overall
fold is different from that of classical peroxidases or P450s. In CPO, the proximal heme
ligand, Cys 29, is located in the N-terminal part of the protein in the N-terminus of the
helix A (residues 29-38) that is almost perpendicular to the heme plane (71). In CYPs and
other peroxidases, the proximal ligand is situated in the C-terminal domain of the protein
in the N-terminus of the helix that is parallel to the heme (98). It has been proposed that
electropositive environment of helix A at the N-terminus fine-tunes the electronegativity
of the proximal Cys and influences structural, catalytic, and ligand binding properties of
CPO (88, 99, 100).

Figure 1.4. Crystal structure of chloroperoxidase from C. fumago. The following PDB file
was used to visualize CPO: 1CPO (71). Heme is depicted in purple color. Letters indicate
different helices in CPO structure.
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The proximal Cys in CPO is hydrogen-bonded (H-bonded) to the peptide NH groups
of Ala 31 and Leu 32 situated at the N-terminus of the helix A. Hydrogen bonding between
Cys and polypeptide amides is a common feature of other thiolate proteins including P450s,
in which proximal Cys 357 is H-bonded to NH groups of Leu 358, Gly 359, and Gln 360
(98). These H-bonds contribute to the increase of the iron redox potential by decreasing
the negative charge on the Cys ligand, and stabilize the thiolate by preventing its
protonation and protecting against diatomic reactants, all of which result in the formation
of inactive forms of the enzyme (101, 102).
The active site of CPO shares common structural features with both peroxidases and
P450 enzymes (Figs. 1.2 and 1.3). In CPO, the heme iron is coordinated to the proximal
Cys, similarly to P450s and in contrast to the proximal His of traditional peroxidases (71).
However, the distal pocket of CPO, which is similar to that of classical peroxidases, is
dramatically different from that of P450s which contains mainly non-polar residues. Some
distal residues are involved in the formation of Compound I (Cpd I), an active species in
the catalytic cycle of most heme enzymes. In classical peroxidases, the distal His is
hydrogen-bonded to an Arg residue and is responsible for the peroxide bond cleavage in
Cpd I formation. In CPO however, this function is carried out by Glu 183, which is
hydrogen-bonded to the distal His 105. Arginine and histidine provide a particular
orientation to the His and Glu, respectively. Therefore, the CPO active site environment is
somewhat similar to other peroxidases in terms of polarity and spacial arrangement;
however, it also resembles p450-type enzymes because of the thiolate proximal ligand as
well as possessing direct accessibility to the heme through a wide channel (Fig. 1.5).
Access to the heme is typically restricted in classical peroxidases (103). CPO’s wide
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channel provides access to bulky substrates, such as those involved in oxygen insertion
reactions, and is likely to be responsible for the observed enantioselectivity of CPO. In
addition, there is a narrow channel connecting the heme center with the protein surface.
Bulky and hydrophobic residues make up the narrow channel near the heme center, while
small and polar residues are located near the exit to the protein surface. The narrow channel
contains multiple halide binding sites and is proposed to provide halogen ion access to the
CPO active site. It should be noted that in peroxidases the heme access by substrates is
restricted; however, the heme edge is accessible by substrates for one-electron oxidations,
which is in contrast to CPO whose heme edge is inaccessible to most substrates (71, 103).
It is likely that the unique and unusual structure of CPO facilitates its diverse catalytic
capabilities.

Figure 1.5. Slice through surface representation of CPO. The two channels are marked by
arrows, and the heme is shown in magenta. The bromide and iodide binding sites are
depicted by yellow and blue spheres, respectively (103).
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1.3.2 Overview of CPO catalytic cycle
As previously mentioned, CPO is unique because it is able to catalyze various
reactions that are usually performed by different groups of enzymes. The catalytic
pathways are summarized in the diagram created by L. P. Hager (Fig. 1.6).
The initial step of CPO catalytic cycle is the conversion of the native ferric enzyme
(resting state) to the oxo-ferryl cation-radical intermediate ([Fe4+=O]·+) called Compound
I. In many heme enzymes, Cpd I is efficient in catalyzing only one particular type of
reaction, depending on the class of the enzyme. In the case of CPO, however, once Cpd I
is formed, it is able to follow different catalytic pathways. For example, it can either form
oxo-ferryl Compound II (Cpd II, Fe4+=O, peroxidation pathway), oxo-ferric Compound X
(Cpd X, Fe3+=O, halogenation pathway), or return to its resting state (Fe3+, dismutation and
P450 pathways). Such catalytic diversity distinguishes CPO from other biocatalysts and
attracts the attention of scientists from various fields.

Figure 1.6. Catalytic cycle of CPO (created by L. P Hager).
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1.3.2.1 Active intermediates: Compound I, Compound II, and Compound X.
Compound I, an oxo-ferryl cation-radical, is an active intermediate in the catalytic
cycle of all reactions catalyzed by CPO and is similar to that in other heme enzymes (104).
The mechanism of Cpd I formation begins with the formation of Compound 0, as proposed
by Chen et al. (Fig. 1.7) (105). An oxygen atom of hydrogen peroxide binds to the heme
iron to form Fe(III)HOOH in two possible conformations, depending on whether Glu183
hydrogen bonds to the hydrogen of the proximal or distal oxygen. However, Shaik et al.
have shown that interactions with the distal hydrogen will not lead to the production of
Cpd I, which leaves the first possibility. In this conformation, Glu 183 abstracts a proximal
proton concomitantly with the movement of the –OOH group about the z-axis of the heme
plane, resulting in formation of Cpd 0, in which protonated Glu 183 is hydrogen bonded to
the distal oxygen. In the next step, Glu 183 protonates distal oxygen and upon water release,
Cpd I is formed. Interestingly, the rate of Cpd I formation was shown to be only slightly
dependent on the nature of the proximal ligand and independent of pH. However, the axial
ligand might influence the stability and reactivity of Cpd I as was shown in cytochrome c
peroxidase (106).
Another intermediate, Cpd II, is an oxo-ferryl species in the peroxidation pathway of
CPO formed from Cpd I. The X-ray absorption fine structure study by Green et al. has
demonstrated that there are three species of Cpd II (107). It was postulated that the major
species of Cpd II is in the protonated form, while the minor species is in the de-protonated
form. The third species had a low yield (6%) and could not be assigned. A computational
study by Lai et al. further explored the nature of Cpd II and assigned both the major and
minor species to be iron(IV)-hydroxide species, differing only in hydrogen bonding with
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either a water molecule or Glu 183 (108). The third species was tentatively assigned to be
an iron(III)-hydroxide cation radical; however, no experimental data have confirmed the
nature of Cpd II proposed by Green and Lai.

Figure 1.7. Mechanism of CPO Compound I formation, the horizontal bold line represents
the porphyrin ring (105).
Compound X is an intermediate in the halogenation pathway and is also formed from
Cpd I. In the synthetic enzyme model, Cpd X was formed upon addition of Cl- to Cpd I to
produce a ferric Fe-OCl- intermediate (109). Ferric Fe-OCl- was unable to chlorinate
monochlorodimedone (MCD), which is a common substrate used in chlorination reactions.
In contrast, the protonated species Fe-HOCl converted MCD into dichlorodimedone
(DCD). That explains the reactivity of CPO at a low pH. The proposed reaction mechanism
for chlorination reaction is shown in Figure 1.8 (110).
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Figure 1.8. CPO-catalyzed chlorination mechanism (110).
1.3.3 Reactions catalyzed by CPO
As mentioned earlier, CPO is one of the most versatile heme enzymes, capable of
catalyzing a plethora of oxidation reactions. One-electron oxidations occur via the
peroxidation pathway while two-electron oxidations occur via the halogenation, oxygen
insertion, and dismutation pathways (111-113). Chloroperoxidase is able to oxidize a
variety of substrates including amines, alcohols, alkenes, esters, anisoles, sulfides, and
indoles (111, 114-126).
1.3.3.1 One-electron oxidations
One-electron oxidations include peroxidation and oxidative de-halogenation
reactions. Chloroperoxidase catalyzes peroxidations with less efficiency than classical
peroxidases such as horseradish peroxidase and lignin peroxidase (127). Peroxidatic
reactions occur on the surface of the enzyme (Fig. 1.9b) (112) via two one-electron transfer
steps and involve formation of Cpd I and Cpd II intermediates (Reactions 1.1-1.4). In
mechanisms of classical peroxidases (Fig 1.9), c was determined to be the rate-limiting
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step, while for CPO, the rates difference between b and c is smaller than that in other
peroxidases (127).

Figure 1.9. Mechanistic routes of different types of reactions catalyzed by CPO:
(a) halogenation, (b) phenol oxidation, (c) sulfoxidation (113).

2R-H + H 2 O 2

R-R + 2H 2 O

(1.1)

a. Enzyme + H 2 O 2

Cpd I + H 2 O

(1.2)

b. Cpd I + RH

Cpd II + R•

(1.3)

c. Cpd II + RH

Enzyme + R•

(1.4)

Peroxidation reactions are pH-dependent with the highest rates achieved at acidic pH
(128), which may indicate the requirement for Cpd II protonation and/or higher heme redox
potential at low pH. Typical substrates in one-electron reactions are aromatic hydrocarbons
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including ABTS (Fig. 1.10) and guaiacol that are commonly used to assay peroxidatic
activities of enzymes (129, 130). Few data are available on the mechanism of peroxidation
reactions catalyzed by CPO, and there is an ongoing debate regarding the site at which oneelectron oxidations take place. Casella et al. reported that phenols possessing bulky
substituents and bearing free amino groups were poor substrates for oxidation by CPO
(131). In addition, CPO stereoselectively catalyzed the L-isomer of N-acetyltyrosine, but
not the D-isomer. These results indicate that CPO’s substrate selectivity is determined by
size, charge, and the particular orientation of a molecule in the active site of the enzyme.
Preference of smaller or para-substituted phenols as well as molecules lacking positive
charge has been attributed to the rigidity of the access channel and the presence of positive
amino acids in the active site, respectively. However, a more recent report by Manoj and
Hager (112) argues that peroxidations most likely occur on the protein surface and not at
the active site, on the basis of observed oxidations of bulky meta-substituted phenolics,
benzylidene bis-dimethylaniline, and N′,N′,N′,N′-tetrabenzyl phenylenediamine, which are
too big to fit into the active site of CPO. In addition, CPO treated with dialkyl
pyrocarbonate is unable to perform reactions that require substrate binding to the active
site, but retains its peroxidatic ability. Furthermore, different pH optima were reported for
different substrates as well as for chloride-free and chloride-assisted peroxidations (132).
These results suggest the possibility of two different peroxidation mechanisms and/or
reaction sites.
Enzymatically catalyzed peroxidative reactions are of great interest to the public since
they may be used to eliminate phenolic contaminants from water, degrade azo dyes utilized
in textile industry, synthesize phenolic polymers as a healthier alternative to harmful
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phenol-formaldehyde methods (133, 134), remove lignin degradation products generated
by wood decomposition for bio-fuel production, etc. (135, 136).
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Figure 1.10. Oxidation of ABTS by CPO using hydrogen peroxide as an oxidant.
Another reaction that occurs via two one-electron transfer steps with Cpd I and Cpd II
intermediates is the oxidative dehalogenation reported by Osborne et al. (137, 138) and
further investigated by Murphy (139) and Diaz-Diaz (140). The substrates analyzed
included trihalophenols and monofluorophenols (Fig. 1.11). In contrast to halogenation,
where CPO is unable to use fluoride as a halogen source, CPO has been shown to catalyze
defluorination. The discovery of this new reactivity of CPO has significant environmental
implications. In particular, introduction of toxic chlorinated phenols into the environment
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by industrial processes is a growing concern and effective methods of phenol degradation
are needed. Thus, CPO has a potential to be used in catalytic bioremediation of toxic
compounds and help create healthier environment.

OH
X

O
X

X

a)

b)

X

X

O

OH

O

F

O

Figure 1.11. Dehalogenation of (a) trihalophenol, where X = F-, Cl-, Br-, I- and (b)
4-fluorophenol.
1.3.3.2 Two-electron oxidations
Two-electron oxidations include a variety of reactions such as halogenations,
peroxygenations, peroxide dismutations, and have been proposed to occur at the active site
of CPO, with the exception of halogenations (Figs. 1.9a and 1.9c) (112,113, 141, 142). The
signature function of CPO is chlorination; however, it is also able to use bromide and iodide
to halogenate various substrates as depicted in the reaction below, where X- includes Cl-,
Br-, and I- :

RH + H 2 O 2 + X- + H+

R-X +2H 2 O
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(1.5)

Chloroperoxidase is unable to use hydrogen peroxide to oxidize fluoride ion since such a
reaction is thermodynamically unfavorable (28). Halogenation involves formation of Cpd
X and is most efficient at low pH with an optimum pH of 2.75 for CPO (132, 143). It has
been debated whether halogenations occur in the active site of CPO or via diffusible
intermediate(s). Manoj investigated those two possibilities in chlorination reactions of 35
different substrates, and proposed that final chlorine transfer occurs outside the active site
of CPO (141). This statement was derived from the observations that substrate size and
topography had no significant effect on chlorination rates, and substrates larger that the
active site dimensions were effectively chlorinated.
Substrates susceptible to halogenation by CPO include β-diketones, phenols (28), βketo acids (27), tyrosine, thyroglobulin (144), alkenes (143), alkynes (118), and aromatic
hydrocarbons (145). A few examples are shown in Figure 1.12. It should be noted that
halogenation occurs non-stereoselectively (146) and with a difference in an intermediate
formation between chlorination/bromination and iodination reactions. In the former two
types of reactions there is no formation of halogen molecule while in the latter reaction
iodide is oxidized into iodine intermediate (28, 143).
Other two-electron oxidations include oxygen insertions and other oxidative reactions.
Oxygen insertions can be divided into epoxidations, sulfoxidations, and hydroxylations,
which occur stereo- and regio-selectively (124, 147, 148). Stereoselectivity arises from the
fact that to gain access to CPO’s active site, the substrates need to properly orient in the
channel that connects the surface of the enzyme to the heme pocket. Substrates for these
two-electron oxidations include amines, alcohols, aldehydes, alkenes, alkynes, esters,
anisoles, sulfides and indoles (111-112, 115-126).
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Figure 1.12. Examples of CPO-catalyzed halogenations : (a) 1,3cyclopentanedione, (b) phenol, (c) alkene, (d) anthracene (aromatic hydrocarbon).
Epoxidation reactions occur stereoselectively via oxygen transfer from hydrogen
peroxide or organic peroxide to form epoxide products (34):

O

R

R'

R

R'

(1.6)

In CPO, the nature of intermediates involved in epoxidation has not been elucidated yet;
however, it has been suggested that epoxidation might occur via a dual pathway involving
two different transition states (Fig. 1.13) (149).
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`
Figure 1.13. Possible transition states in epoxidation of cis-2-methylstyrene (149).
Chloroperoxidase catalyzes epoxidation of cis-disubstituted, 1,1-disubstituted, and
tri-substituted alkenes that possess not more than 8 carbons, producing epoxides with the
R-configuration as the major product. The highest enantiomeric excess and yields are
obtained for cis-disubstituted olefins (Fig.1.14). Interestingly, trans-olefins and terminal
alkenes were found to be poor substrates for CPO (147) as well as mono-substituted
alkenes (150).
O

100%, ee 95%

a)
O

O
O

b)

OEt

OEt

67%, ee 93%

Figure 1.14. Stereoselective epoxidation of (a) cis-heptene and (b) 3-methyl-3butenoate
with yield and enantiomeric excess (ee) percentages.
Chiral epoxides are of great interest to pharmaceutical and chemical industries since
they can be used as synthetic precursors to drugs and natural products (151). Currently,
enantiopure drugs can be synthesized by high-cost multi-step organic methods which
produce large amounts of toxic by-products and low yields of the compounds of interest
(128, 152). Non-toxic, environment-friendly synthesis via enzymatic catalysis is thus a
very promising alternative; however, there are some difficulties associated with the largescale utilization of CPO for epoxide production.

24

One of the challenges in epoxidation reactions is determining the appropriate amount
of the hydrogen peroxide oxidant to be used since large amounts of the oxidant cause
oxidative damage to CPO. Another issue is the hydrogen peroxide dismutation ability of
CPO (Eq. 1.7), which depletes the oxidant before significant yields of the desired product
is produced. Decreased product yield is the result of competition between hydrogen
peroxide and the desired substrate for the particular reaction with Cpd I (153). Sometimes,
other commonly used oxidants such as iodosobenzene and tert-butyl hydroperoxide can be
substituted for hydrogen peroxide as is the case with functionalized cis-olefins (121).
However, many simple unfunctionalized cis-alkenes require H 2 O 2 for the epoxidation to
occur (147).

2H 2 O 2

O 2 + 2H 2 O

(1.7)

Despite difficulties of epoxidations, there are several examples of successful
applications of CPO in the production of special pharmaceutical compounds including
synthesis of R-(-)-mevalonolactone (154) and (R)-dimethyl 2-methylaziridine-1,2dicarboxylate (155) that are important precursors for pentanoid compounds and alphamethylamino acids, respectively.
Another two-electron oxidation catalyzed by CPO is the stereoselective sulfoxidation
of organosulfides (Eq. 1.8), producing mainly R-sulfoxides (142, 156-158):

O
R

S

R'

R

S

R'

(1.8)

Several substrates such as aromatic and β-carbonyl sulfides (157-160) were studied by
different research teams. As with the epoxidation reaction, the size and nature of substrates
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as well as the choice of the oxidant play an important role in product yield and enantiomeric
excess (Fig. 1.15) (148, 160). Bulky substrates are either poorly oxidized or not oxidized
at all. Para-substituted aryl alkyl sulfides or sulfides containing electron-donating groups
on the benzene ring are more easily oxidized than ortho-substituted sulfides or sulfides
containing electron-withdrawing groups. As for the oxidants, tert-butyl hydroperoxide and
hydrogen peroxide are more effective than other oxidants in sulfide oxidations, giving
increased product yields and enantioselectivity (157). Additionally, the manner in which
the oxidant is introduced into the reaction system is critical for obtaining high yields of
enantiopure products. The concentration of the oxidant must be kept low to prevent H 2 O 2
accumulation, which hinders the reaction by inactivating the enzyme. A low concentration
of the oxidant can be achieved by continuously adding the oxidant at the rate of the initial
reaction (125).
Many CPO-catalyzed sulfoxidations have environmental and biomedical significance.
One of the examples of this utility is the removal of organosulfur from diesel fuel to reduce
harmful effects on the environment. Chloroperoxidase converts organosulfides into the
corresponding sulfones and sulfoxides, which can be effectively eliminated by distillation
(152, 161). Another example is CPO-catalyzed synthesis of (R)-modafinil, which is used
to treat sleep disorders and narcolepsy (162).
The next type of oxidation to be discussed will be hydroxylation, which can be
stereoselective or nonstereoselective, depending on reaction conditions. Additionally,
hydroxylation most likely occurs via the oxygen insertion pathway as determined by Zaks
and Dodds (117). A dual pathway for CPO-catalyzed hydroxylations was proposed based
on hydroxylations catalyzed by P450s (Fig. 1.16) (149). The first one involves an oxo-
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ferryl species with transition state 20 while the other one involves ferric hydroperoxide
species with transition state 21 (Fig. 1.16). However, the mechanism of hydroxylation
remains to be elucidated.
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Figure 1.15. Stereoselective sulfoxidation of (a,b) beta-carbonyl sulfides and (c,d,e) aryl
sulfides with yield and enantiomeric excess (ee) percentages. The nature and size of the
substrate influence the yield and ee values.
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Figure 1.16. Dual mechanism proposed for CPO-catalyzed hydroxylations (149).
As with other oxidation reactions, the oxygen in hydroxylation comes from an oxidant
such as hydrogen peroxide (124). In contrast with epoxidation and sulfoxidation reactions,
hydroxylation products can have either R (2-phenethyl alcohol) or S (1-phenyl-1-propanol)
configuration (117). Among the substrates of CPO that undergo hydroxylation are pmethylanisole and p-ethylanisole (124), functionalized and unfunctionalized acetylenes
(121), cyclic conjugated dienes (163, 164), and R-(+)-limonene that belongs to
monoterpenes (165). As with aryl sulfides, benzylic compounds containing orthosubstitutions are poorly hydroxylated or not hydroxylated at all. The degree to which the
reaction proceeds is determined by substrate oxidation potential, nature of substituents, and
steric requirements (124).
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The stereoselectivity of CPO-catalyzed hydroxylation is dependent on the nature of
the substrate. In reactions with 1,3-cyclohexadienes, the product of the reaction with 2hydroxyphenol has an enantiomeric excess of 78% while 1,3-cyclohexadiene diacetate is
converted into a racemic mixture (Fig. 1.17) (163). The presence of chloride in the reaction
may influence the enantiomeric excess as observed with the R-(+)-limonene, which is
converted into a single enantiomer (99%) when there is no chloride, while a racemic
product is formed if chloride is present (Fig. 1.18) (165). The loss of stereoselectivity when
chloride is present suggests that chloride ions may be converted to hypochlorite, which in
turn oxidizes limonene without stereoselectivity. Thus, CPO-catalyzed hydroxylations are
less stereoselective than epoxidations or sulfoxidations. However, with carefully controlled
conditions, useful enantiopure products can be obtained, such as during halo-hydroxylation
of chloropropene and allyl alcohol to prepare chiral precursors for agrochemical and
pharmaceutical industries (166). The side reactions that need to be controlled include
further oxidation of alcohols to aldehydes and oxidant dismutation (122).
In addition to the reactions described above, CPO is able to catalyze the oxidation of
different monoterpenes in the presence of halide to yield halohydrins (167), regio- and
stereoselective bromohydration of glycals to produce 2-deoxy-2-bromo saccharides (168),
oxidation of unsubstituted and substituted indoles to yield oxindoles (125, 169, 170), Noxidation of arylamines to give nitroso metabolites (111, 169, 171), oxidation of alcohols
to aldehydes (116), and oxidation of conjugated dienoic esters to yield a variety of products
(123). Many of the above compounds can be converted into chemicals that serve as
intermediates in the synthesis of flavors, fragrances, and drugs (125, 167).
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Figure 1.17. Hydroxylation of 1,3-cyclohexadienes catalyzed by CPO. The nature and size
of the substrate influence the yield and ee values.
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Figure 1.18. Oxidation of R-(+)-limonene catalyzed by CPO in the presence and absence
of KCl.
1.3.4 Ligand-binding properties
Despite similarities between spectroscopic properties of CPO and P-450cam (172), in
terms of ligand-binding properties, CPO has a closer relationship to peroxidases. Many
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ligands except for the halides, acetate, and nitrate, form low-spin complexes with CPO
(173, 174). Since weakly acidic ligands with pKa 3.2-9.14 (cyanide, pyridine, imidazole,
fluoride) bind to ferric CPO in their neutral form and lose their proton upon ligation, the
binding affinity is decreased above their pKa. In contrast, very acidic ligands with negative
pKa (thiocyanate, nitrate, chloride, bromide, and iodide) seem to bind in their anionic form
and display varying affinities in pH range 2-7. For neutral ligands such as carbon monoxide
and n-butyl isocyanide, no changes in affinity were observed at various pH. It has been
suggested that for ligand binding to ferric CPO, an amino acid with a pKa less than 2 is
involved, while a group with the pKa of 5.5 is involved in ligand binding to ferrous form
of the enzyme (174).
Carbon monoxide and cyanide have high affinities for CPO and most heme proteins
in general, and make open crevice structures more stable (175). Interestingly, when
diatomic and triatomic ligands bind in the distal site of CPO, they do so without requiring
movement of the distal residues to accommodate those ligands (176). Instead, the distal
Glu 183 interacts with ligands either electrostatically or via hydrogen bonding. This
becomes very important during the formation of Cpd I when hydrogen peroxide binds to
the heme, and Glu 183 acts as an acid-base catalyst to promote O-O scission and release of
water (176).
1.4 Spectroscopic properties of heme proteins
Electronic absorption, resonance Raman (RR), nuclear magnetic resonance (NMR),
and circular dichroism (CD) spectroscopies are frequently used to investigate heme
proteins. Electronic absorption spectroscopy or UV-Vis spectrophotometry, can be used to
investigate electronic structure of heme and its environment, i. e., the coordination and spin
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state of the heme iron. A typical absorbance spectrum of a heme protein (Fig. 1.19) (177)
includes a peak at around 400 nm called the Soret band and minor peaks in 500-700 nm
region called Q bands that result from transitions in the porphyrin (Fig. 1.20) (178).

Figure 1.19. A typical electronic absorption spectrum of a heme protein (177).
The Soret and Q bands both arise from π–π* transitions and can be explained using
the Gouterman four orbital model that was proposed in the early 1960s (178). According
to this model, transitions between two highest occupied molecular orbitals (HOMOs) and
two lowest unoccupied molecular orbitals (LUMOs) produce these absorption bands and
their relative energies depend on the substituents on the porphyrin ring and the identity of
the metal center. The Soret peak is a result of a strong transition to the second excited state
(S2) while minor peaks are the result of weak transitions to the first excited state (S1).
Furthermore, the Q band that results from a transition from the resting state to the S1
vibrational ground state is called the α band while the Q band due to transitions to higher
vibrational levels in the S1 is called the β band and appears at slightly lower wavelengths
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than the α band. The intensities of the α and β bands relative to each other can serve as a
measure of how close in energy the a 2u and a 1u orbitals are. For instance, if both orbitals
are very similar in energy, the degree of orbital mixing will be large. In this case, the α
band intensity will be small and the α/β intensity ratio will be small as well. On the contrary,
if the a 2u and a 1u orbitals have very different energies, the α/β intensity ratio will be larger
because of the smaller degree of orbital mixing (179).

Figure 1.20. The Gouterman four orbital model.
Other interactions that can be observed with UV-Vis spectrophotometry include
porphyrin - iron interactions. Since ferrous iron has filled d π orbitals (d6), ferrous heme is
a hypsoporphyrin in which the interactions between iron d π (d(xz), d(yz)) and porphyrin
π* (a 1u ) orbitals are significantly stronger. These strong interactions result in a larger
porphyrin π to π* (a 2u to a 1u ) energy difference, causing the hypsochromic (blue) shifts in
the electronic spectra (Fig. 1.21). In contrast, in regular metalloporphyrins with closed dshells (d0 or d10), the d π metal orbitals have little effect on the π to π* energy separation in
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porphyrin electronic spectra because of their low energy (180).

Figure 1.21. Interactions between iron d π (d(xz), d(yz)) and porphyrin π* (a 1u ) orbitals.
Resonance Raman spectroscopy is used to monitor structural changes in the heme
upon ligand binding and electron transfer (181). In the Raman spectrum of a heme protein,
several bands in the high-frequency region are associated with vibrations of porphyrin
substituents while bands in the low-frequency region arise from vibrations of the axial
ligands. Thus, resonance Raman spectroscopy can be used to investigate the structure of a
heme center, as well as the spin of the iron and the nature of the proximal and distal ligands
(182).
Proton NMR is another powerful technique that allows structural characterization of
hemoproteins. Although it has been challenging to assign all heme protons in the NMR
spectrum for CPO, it is a useful technique for verifying the proximal ligand substitutions,
as well as assessing other important residues in the active site of CPO (183). The broad
resonances make it difficult to analyze a proton NMR spectrum of a native high-spin heme
protein. Thus, the cyanide-bound low-spin protein complex may be analyzed to obtain
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information on electronic and molecular structural properties.
Circular dichroism can be utilized in the determination of protein alpha-helical and
beta-sheet content as well as for monitoring of secondary and tertiary structural changes in
mutant proteins or protein-ligand complexes. Several programs, such as CONTINLL (184,
185), SELCON3 (186, 187), CDSSTR (188-190), VARSLC (188, 189), and K2D (191) are
available for estimation of the protein secondary structures. The algorithms differ in the
number and nature of the reference protein sets used in analysis, thus one method might be
more suitable than others for a particular protein. As for tertiary structure CD, it is useful
for confirming the integrity of protein domains expressed separately, investigating protein
stability under changing conditions, and observing structural alterations in mutants or upon
ligand binding. For heme proteins, CD may also provide information on changes in the
environment of the heme group (192). Additionally, it is possible to assign a protein to a
particular class (all alpha, all beta, alpha+beta, alpha/beta, denatured) based on the method
developed by Venyanimov and Vassilenko (193), which is especially useful for new
understudied proteins.
1.5 Site-directed mutagenesis to study structure-function relationships in heme
proteins
Heme enzymes are attractive targets for protein engineering because of their catalytic
diversity. There are four approaches to constructing heme enzymes with desired catalytic
and substrate-binding properties: modification of the heme group, exon shuffling of
hemoglobin, directed evolution, and rational design (194). In my study, I employ the latter
approach using site-directed mutagenesis to explore how changes in the proximal active
site affect biochemical properties of CPO. Many heme protein mutants have been prepared
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using site-directed mutagenesis to gain insights into the role of the heme environment in
catalysis and substrate specificity. The results of several of those studies are summarized
in Table 1.3.
Table 1.3. Effects of distal and proximal active site mutations on catalytic activities of
some heme proteins.
Protein/Mutation

Activity Changes

References

Mb
F43H/H64L
(distal His relocation)

Increased peroxidase, epoxidase, and (195)
sulfoxidase activities, increase in heme
iron-distal His distance from 4.3Å to 5.7Å
(similar to peroxidases)

L29H/H64L
(distal His relocation)

Decreased peroxidase activity, increase in (195)
heme iron-distal His distance from 4.3Å
to 6.6Å (too far for efficient H 2 O 2
activation)

H64D
(distal His substitution)

Increased
peroxidase
activity, (195)
replacement with aspartate that can act as
acid-base catalyst in formarion of Cpd I

H93Y
(proximal His substitution)

Decrease in catalase activity, possibly (196)
poor H 2 O 2 binding

HRP
R38H, R38H/H42V
(distal His relocation)

Decreased peroxidase activity, but (197)
increased sulfoxidation and epoxidation,
better access to the active site

H42E, H42Q
(distal His substitution)

Decreased
peroxidase
activity, (198)
suboptimal orientation of E lacking Hbonding with N70

F41A
(increase in heme access)

Similar peroxidase activity to wild-type (199)
(WT), increased sulfoxidation and
epoxidation
(200)

N70V, N70D
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(H-bond disruption)

Decreased peroxidation, deletion of Hbonding between H42 and N70

CcP
W51H/H52L
W51H/H52W
(distal His relocation)

Decreased catalytic activity because of the (201)
slower reaction with H 2 O 2

H52D, H52E, H52N, H52Q Decreased activity because of the slower (202)
rates of Cpd I formation
(distal His substitution)
Increased activity

(106)

T96A, T96F
(distal Tyr substitution)

Increased hydroxylation

(203)

C357U

Decreased oxygenase activity

(204)

H175E
(proximal His substitution)
P450cam

P450175A1
L80H, L80Q
(distal Leu substitution)

(205)
Increased peroxidase activity
(pH dependence, increase in basicity of H
and Q and pKa increase of peroxide more
active at basic pH)

CPO
E183H
(distal Glu substitution)

Decreased chlorination and dismutation, (206)
increased epoxidation.

From the data above, it is evident that there are multiple factors that regulate redox
potentials and catalytic activities of heme enzymes. These factors include the nature of the
proximal ligand, the heme iron-ligand distance, the nature of a distal acid-base catalyst,
hydrogen bonding networks in both distal and proximal heme pockets, polarity of the active
site, and the accessibility of the active site by substrates.
To better understand structure-function relationships in this class of proteins, several
mutagenesis studies were performed on such heme proteins as myoglobin, horseradish
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peroxidase, and cytochrome c peroxidases. Despite the fact that CPO from C. fumago was
discovered in 1966, it is still poorly understood how CPO directs catalysis of such a broad
range of reactions and substrates. There is much debate about the importance of the
proximal thiolate ligation in CPO as well as contributions of other structural features in
defining biochemical properties of this enzyme.
In my work, I utilized site-directed mutagenesis to introduce single or double amino
acid substitutions in the active site of CPO in order to explore their roles in the structure
and catalysis of this protein. I concentrated my attention on the proximal region of the heme
pocket, and investigated the importance of Cys 29 as well as the hydrogen bond network
between Arg 26 – Asn 37 and Ala 27 – Asn 33 for biochemical properties of CPO. Since
there is no consensus on the role of Cys 29 in CPO catalysis, I chose to substitute Cys 29
with a His to imitate proximal ligation of a classical peroxidase and investigate the
properties of the mutant. Furthermore, I replaced Arg 26 and Asn 33 with Ala in R26A,
N33A, and R26A/N33A mutants to disrupt the hydrogen bond network. It is reasonable to
suggest that these hydrogen bonds are important for maintaining the particular tertiary
structure of CPO, and possibly, for catalysis. Since no data are available on the role of
hydrogen bonds in the proximal pocket of CPO, I chose to investigate how removal of
some or all hydrogen bonds in this network would affect the biochemical properties of this
enzyme. The following chapters will present my findings on the characterization of C29H,
C29H/C79H, C29H/C79H/C87H, R26A, N33A, and R26A/N33A CPO mutants, compare
their biochemical properties to those of WT CPO, and discuss factors that play a significant
role in the structure and function of CPO.
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CHAPTER II.
THE ROLE OF THE PROXIMAL LIGAND IN CPO, A LONG LASTING
DEBATE
2.1 Background
In heme proteins, the nature of the axial ligand together with active site polarity and
electrostatic interactions influence the heme redox potential, which in turn, affects
reactivity (207). Common proximal ligands include histidine (most peroxidases), cysteine
(CPO, UPOs, and P450s), and tyrosine (catalases) (49, 63, 64, 67, 71). The role of the
proximal thiolate ligand in defining the biochemical properties of heme proteins has been
much debated (48, 172, 208-210). It has been suggested that the heme proximal ligation to
a cysteine is responsible for the Soret peak near 450 nm for ferrous CPO – carbon monoxide
(CO) complex, similarly to CO-bound P450 (172, 208). By comparison, carbon monoxide
complexes of heme proteins with His as a proximal ligand absorb near 420 nm (106, 196).
In addition, it has been postulated that thiolate ligand plays a crucial role in the catalytic
diversity of CPO and provides it with the ability to perform chlorination reactions, while
other peroxidases with the imidazole proximal ligation either lack or have a very low level
of chloride oxidation ability (48, 209, 210).
Many site-directed mutagenesis studies have been done on heme proteins with
imidazole and thiolate proximal ligation to understand the role of the proximal ligand in
catalysis of heme proteins and the results of those studies are summarized in Table 2.1.
From the data in Table 2.1, it is evident that substitutions of native proximal ligands
dramatically change the catalytic abilities of heme proteins. However, it is difficult to
clearly define ligand-function relationships. For example, upon substitution of the proximal
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His with a Cys in myoglobin, oxygen insertion reaction rates are increased (196, 211).
However, similar substitution in CcP results in decreased overall activity of the enzyme
(106). Furthermore, replacement of the proximal Cys with a His in P450s results in a
complete loss of oxygenase activity (212-214). However, similar substitution in CPO
results in only slightly decreased epoxidation rates (215).
Table 2.1. Effects of proximal active site mutations on catalytic activities of some heme
proteins.
Protein/Mutation
Mb
H93C

Activity Changes

References

Increased sulfoxidation and epoxidation (196, 211)
rates, decreased dismutation

H64G/H93C,
H64V/H93C

Slightly decreased sulfoxidation rates (211)
because of the hydrophobic distal site

H93Y

Decrease in catalase activity possibly (196)
because of the poor H 2 O 2 binding

HRP
H170A
CcP
H175Q

Loss of peroxidase activity

(199)

Similar activity to WT

(106)

H175E

Increased activity

(106)

H175C
P450 2B4
A298E/C436H

Significant decrease in activity

(106)

P450cam
C357H

C357U
CPO
C29H

Increased peroxidase activity while (212)
complete loss of oxygenase activity
Loss of oxygenase activity
(213, 214)
Significant reduction in hydroxylation
activity
Decreased oxygenase activity

(204)

Chlorination, dismutation, peroxidation, (215)
and epoxidation slightly decreased
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In the present study, I replaced proximal thiolate ligand in CPO with a His to mimic
the ligation in classical peroxidases using site-directed mutagenesis. I utilized such
spectroscopic techniques as proton NMR, CD spectroscopy, and UV-Visible
spectrophotometry to investigate how the Cys 29→His mutation affects structural and
catalytic properties of CPO to gain insights into the role of proximal Cys in CPO and other
thiolate proteins.
2.2 Experimental procedures
2.2.1 Materials
A filamentous fungus, Aspergillus niger, was chosen for expression of the mutant
CPO since expression in C. fumago produces WT CPO background that interferes with
characterization of the mutant. The MGG029 strain A. niger was purchased from American
Type Culture Collection. The plasmid coding for WT CPO (pCPO3.I-Amds) and cotransformation plasmid containing PyrG selection marker (pAB4-1) were purchased from
TNO Microbiology and Systems Biology, Netherlands. The QuikChange II XL sitedirected mutagenesis kit and PfuUltra HF DNA polymerase were purchased from
Stratagene (La Jolla, CA). Restriction enzymes were obtained from New England Biolabs
(Ipswich, MA). Purified oligonucleotide primers were purchased from Eurofins MWG
Operon (Huntsville, AL). De-ionized water for all experiments were prepared freshly by
Milli-Q Biocel (Millipore, Billerica, MA). All other chemicals and materials were
purchased from Fisher Scientific (Waltham, MA) unless otherwise stated.
2.2.2 Construction of C29H CPO gene and plasmid propagation
To probe the structural, spectroscopic, and functional role of proximal ligand in CPO,
the C29H mutation was introduced into the pCPO3.I – AmdS (a PUC19-based 14-kb
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plasmid, Fig. 2.1) via polymerase chain reaction (PCR) amplification using the
QuikChange II XL site-directed mutagenesis kit. The PCR reaction was carried out in
Eppendorf thermal cycler (Mastercycler gradient) using PfuUltra HF DNA polymerase.
The amounts of reagents used in a PCR reaction (total volume = 50µL) are listed in Table
2.2. The following primers were used to introduce the C29H mutation:
Coding strain - C29H primer 1
5’- CTACCGACTCTCGTGCTCCTCACCCAGCTCTGAACGCTCTTG - 3’
Non-coding strain – C29H primer 2
5’- CAAGAGCGTTCAGAGCTGGGTGAGGAGCACGAGAGTCGGTAG - 3’

Figure 2.1. pCPO3.I-AmdS plasmid containing A. niger glucoamylase promoter (PglaA),
CPO gene from C. fumago, A. nidulans anthranilate synthetase terminator (TtrpC), and A.
nidulans acetamidase gene (AmdS) as a selection marker allowing growth on acetamide as
the sole source of nitrogen.
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Table 2.2. Reagents used in the PCR reaction.
Reagent

Amount

10Xreaction buffer

5 µL

pCPO3.I – AmdS

1 µL

Primer 1

125 ng

Primer 2

125 ng

dNTP mix

1 µL

QuikSolution reagent

3 µL

PfuUltra HF polymerase

1 µL

DpnI

1 µL

The PCR was performed using the following steps:
1 cycle → 95°C for 1 minute
18 cycles → 95°C for 50 seconds (denaturation)
60°C for 50 seconds (annealing)
68°C for 14 minutes (extension)
1 cycle → 68°C for 7 minutes
The DNA product was digested with Dpn I restriction endonuclease to eliminate native
plasmid. Mutated plasmid was propagated in E. Coli (DH5-α strain), and C29H mutation
was confirmed by DNA sequencing (Fig. 2.2). Before transformation, both pCPO3.I and
pAB4-1 (Fig. 2.3) were verified by DNA digestion and electrophoresis (Fig. 2.4).

Figure 2.2. C29H pCPO sequencing results.

43

Figure 2.3. pAB4-1 plasmid containing A. niger PyrG gene as a selection marker allowing
fungal growth without uridine supplementation.

Figure 2.4. DNA electrophoresis. Restriction digestion of pCPO and pAB4-1. Lanes 1-4:
pCPO3.I-AmdS, lanes 5-8 pAB4-1, lanes 1 and 5 – undigested DNA, lane 2 – HindIII, lane
3 – AflIII, lane 4 – Hind III and AflIII, lane 6 – XbaI, lane 7 – BamHI, lane 8 – XbaI and
BamHI.
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2.2.3 Transformation of Aspergillus niger with C29H pCPO and mutant selection
The pCPO3.I-C29H was co-transformed with pAB4-1 into the protease deficient
MGG029 strain of A. niger (prtT gla::fleor pyrG) using procedures described previously
(97, 216) with the following modifications. Brown conidiospores were inoculated in 50mL minimal medium (MM) containing 0.5% yeast extract, 0.5% Casamino acids, 5%
maltose, 1% glucose, 70mM NaNO 3 , 7 mM KCl, 6 mM KH 2 PO 4 , 6 mM K 2 HPO 4 , 2 mM
MgSO 4 , 10 mM uridine, 25µL of carbenicillin (100 mg/mL stock), 50uL of the Hutner
trace elements solution (217). The mini-culture was incubated at 250 rpm and 37°C for 1
day and then at 30°C until white-yellow mycelium is observed (2-5 days). After disruption
of the mycelium with a homogenizer, the culture was transferred to 1-L MM and incubated
at 30°C and 250 rpm for 16-20 hours followed by protoplast preparation and DNA
transformation using polyethylene glycol as described previously (216). Successful
transformants were selected on polyacrylamide plates lacking uridine supplementation and
used to express the mutant protein.
Each clone from the acrylamide plates was inoculated in 50-ml MM lacking uridine
and yeast extract, and incubated at 250 rpm and 22°C for 1 week. The ABTS assay,
described below, was used to determine the clone with the highest protein yield, which was
used to set up large scale protein expression.
2.2.4

Expression and purification of C29H CPO

The A. niger spores (1 plate per 1 L medium) were inoculated into 48-L MM lacking
uridine and yeast extract and containing 10% fructose, carbenicillin (50 mg/L), and 100
µM δ-aminolevulinic acid. Cultures were incubated at 250 rpm and 25°C for 3 days and
then at 22°C for 4 more days. Then, the medium was filtered through glass fiber filter
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circles G6 and concentrated down to 50 mL in the Amicon stirring pressure cells.
Concentrated sample was dialyzed against 25 mM phosphate buffer, pH 5.9 and filtered
through 0.45 µm membrane.
Mutant CPO was purified using AKTA prime chromatography system. All buffers
used during purification were filtered through 0.45 µm membrane and de-gassed for 15
minutes. The protein sample (50 mL) in 25 mM phosphate buffer, pH 5.9 was filtered
through 0.45 µm membrane and applied onto a 100-mL column packed with 50 mL of
diethylaminoethanol (DEAE) sepharose resin, and washed with 25 mM phosphate buffer,
pH 5.9 while gradually increasing NaCl concentration. The C29H CPO eluted at
approximately 30% 0.5 M NaCl. Fractions with Reinheitzahl (RZ) values (A 420 /A 280 )
above 0.7 were combined and concentrated down to about 1 mL using Millipore 30,000
centrifugal filter unit. The sample was filtered through 0.45 µm membrane and applied
onto a gel filtration column containing 500 mL of Sephadex G75 resin and eluted with 25
mM phosphate buffer, pH 5.9 (Fig. 2.5).

Figure 2.5. C29H CPO sample loaded on a gel filtration column.

46

Fractions with RZ values between 1.2 – 1.5 were used in all subsequent studies. Purity of
the mutant CPO was assessed by sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS-PAGE) (Fig. 2.6).

Figure 2.6. SDS-PAGE. WT and C29H CPO. Lanes 1 and 2 – C29H, lane 3 – WT CPO.
2.2.5

Spectroscopic characterization of C29H CPO
Structural characterization of C29H CPO was performed using 600MHz nuclear

magnetic resonance spectrometer, JASCO CD spectrometer, and VARIAN UV-Vis
spectrophotometer (Cary 300 Bio).
2.2.5.1 Proton nuclear magnetic resonance spectroscopy
Proton nuclear magnetic resonance (NMR) spectroscopy was used to confirm C29H
mutation of CPO. A 600-MHz NMR spectrometer was used to investigate the NMR
spectral properties of the ferric low-spin cyanide complexes of C29H CPO in comparison
with cyanide complexes of HRP and WT CPO. HRP was chosen for comparison since it is
a classical peroxidase with the imidazole proximal ligation. The spectra of the enzyme-CNcomplexes in deuterated phosphate buffer were taken at room temperature. I chose to work
with dCPO-CN complexes since the high-spin nature of WT dCPO produces broad spectral
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resonances providing limited information about the structure of the protein. When bound
to cyanide, heme iron in WT CPO converts to a low spin, and protein-CN complex
spectrum can provide more information about structural properties of the active site than
the native ferric form of the protein.
The spectra of a 0.8 mM cyanide-bound C29H CPO (RZ=1.2), 1.0 mM WT CPO, and
1.0 mM HRP were collected in a 5-mm NMR tubes. Protein samples were exchanged with
deuterated 25 mM potassium phosphate buffer before analysis using Centricon from
Amicon. Protein-cyanide complexes were prepared by addition of an excess amount of
freshly prepared 1M KCN in deuterated phosphate buffer, pH 5.9. The concentration of the
C29H sample was estimated from the theoretical extinction coefficient of 44,015 M-1 cm-1
at 280 nm as calculated by ProtParam tool (expasy.org). For WT CPO, the signals in the
downfield region represent protons from amino acid residues in the proximal and distal
sites of CPO and heme substituents while upfield shifts belong to beta-protons of amino
acid residues near the center and the heme propionate and vinyl groups (183).
2.2.5.2 Circular dichroism spectroscopy
The CD spectra of 1 µM C29H and WT CPO in 5 mM sodium acetate buffer, pH 5.5
were collected in the 190-260 nm range at room temperature using 5-mm quartz cuvettes.
Three spectra were averaged for each protein. The secondary structures were determined
using CDSSTR method and reference #4 (218). CDSSTR is a program that performs
calculations of the secondary structures using a particular number of proteins in the
reference set. Those proteins that do not reflect characteristics of the test protein are
removed from the basis set, and secondary structures are assigned by the singular value
decomposition algorithm (DICHROWEB).
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2.2.5.3 UV-Visible spectrophotometry
The UV-Vis absorption spectra of C29H and WT CPO in phosphate buffer, pH 5.9
were collected in the 250-700 nm range at room temperature using 1-cm quartz cuvettes.
Three spectra were averaged for each protein. To study the effect of pH, the spectra of
C29H and WT CPO in 100 mM phosphate-citrate buffer or 100 mM phosphate buffer (pH
2.5 – 10.0) were collected using 1-cm quartz cuvettes at room temperature. Buffer
exchange was performed using PD-10 column from GE Healthcare Life Sciences.
2.2.6

Ligand binding study
Cyanide (CN-) and carbon monoxide (CO) are known substrates for WT CPO (219,

220). The absorption spectra of C29H and WT CPO in 25 mM phosphate buffer, pH 5.9 in
the absence and presence of substrates were collected using 1-cm quartz cuvettes. The
spectra were recorded in 250 – 700 nm range at room temperature using UV-Vis
spectrophotometer. The final concentration of cyanide in the sample was 100 mM. In
CN- binding study, the spectra were collected upon initial addition of the substrate and after
15-minute incubation of the sample at room temperature. For CO binding, WT and C29H
CPO were reduced with sodium dithionite and purged with CO for 1 minute. To eliminate
the possibility of the proximal His to Cys switch, I also prepared C29H/C79H and
C29H/C79H/C87H CPO as described in sections 2.2.2-2.2.4 and performed CO binding
study with those two mutants as well. The primers used to construct C29H/C79H and
C29H/C79H/C87H CPO are given in Fig. A1.
2.2.7

Enzymatic activity assays
All reactions were initiated by the addition of hydrogen peroxide (except for catalase

assay) and monitored for 180 seconds with a UV/Vis spectrophotometer at room
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temperature. The initial rates of reactions were calculated from the linear portions of the
reaction curves.
2.2.7.1 Peroxidation assay (ABTS)
Peroxidase activity of CPO was measured by the oxidation of ABTS that is commonly
used as a substrate to estimate peroxidation activity of heme enzymes (221). The reaction
system consisted of either WT or mutant CPO in 100 mM phosphate-citrate buffer (pH
2.75 - 6.0) containing 36.8 µM ABTS. After H 2 O 2 (3.6 mM) addition, the reaction was
monitored for the formation of oxidized ABTS at 405 nm. Protein amounts used for the
assay at various pH are listed in Table 2.3. The activity of CPO was decreased at higher
pH; therefore, larger amounts of protein were used to detect peroxidation.
Table 2.3. Protein amounts used in ABTS assay at different pH.
pH

WT (µM)

C29H (µM)

2.75

0.003

0.03

3.0, 3.25, 3.5

0.03

0.03

4.0

0.1

0.03

4.5

0.5

0.1

5.0, 5.5

1.0

0.1

6.0

2.0

0.1

2.2.7.2 Chlorination assay (MCD)
The MCD assay was used to determine the chlorination activity of CPO that catalyzes
conversion of MCD into DCD (222). The reaction system consisted of either WT or C29H
CPO in 100 mM phosphate-citrate buffer (pH 2.75, 3.0, 3.5, 4.0, 4.5, 5.0) containing 20
mM KCl and 0.17 mM MCD. After H 2 O 2 (2.2 mM) addition, the reaction was monitored
at 278 nm, at which MCD absorbs. In the pH range 2.75-4.0, 0.005 µM WT CPO was used
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in the assay while 0.05 µM was used at pH 4.5 and 5.0. As for C29H CPO, 0.6 µM mutant
protein was used in MCD reactions at all pH.
2.2.7.3 Catalatic assay
Catalatic activity was measured by monitoring decomposition of hydrogen peroxide
(34). The reaction system consisted of 0.05% hydrogen peroxide in either 100 mM
phosphate buffer, pH 2.4 or 100 mM phosphate-citrate buffer (pH 3.0, 3.5, 4.0, 4.5, 5.0,
5.5, 6.0). After either 0.5 µM WT or 0.5 µM C29H CPO was added, the reaction was
monitored at 240 nm.
2.2.7.4 Epoxidation assay (styrene)
Styrene epoxidation assay (15) was performed in 100 mM phosphate-citrate buffer
(pH 2.75, 3.0, 3.5, 4.0, 4.5, 6.0, 7.5) containing 0.3 mM styrene and either 0.3 µM WT or
C29H CPO. After addition of 2.2 mM H 2 O 2 , the reaction was monitored at 262 nm, at
which styrene absorbs.
2.2.7.5 Calculations of specific activities
Specific activities (SA) were calculated using equation 2.1 while the change in the
amount of a substrate or product over time was calculated using equation 2.2, where A is
absorbance, ε is the extinction coefficient at a specific wavelength, b is the length of a
pathway, and c is the concentration of the substrate or product.

𝑆𝑆𝑆𝑆 =

µ𝑚𝑚𝑚𝑚𝑚𝑚 𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠 𝑜𝑜𝑜𝑜 𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝/𝑠𝑠𝑠𝑠𝑠𝑠
µ𝑚𝑚𝑚𝑚𝑚𝑚 𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒

𝐴𝐴 = 𝜀𝜀𝜀𝜀𝜀𝜀,

Eq. 2.1

Eq. 2.2

The extinction coefficients used to calculate substrate or product concentration change are
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listed in Table 2.4.
Table 2.4. Extinction coefficients of oxidized ABTS, MCD, hydrogen peroxide, and
styrene.
Substrate or product

Wavelength

Oxidized ABTS

405 nm

Extinction coefficient
(mM-1cm-1)
36.8

MCD

278 nm

12.2

H2O2

240 nm

0.0436

Styrene

262 nm

0.6225

The styrene extinction coefficient at 262 nm was determined to be 0.6225 ± 0.0781 mMcm-1 from the slope of a plot of absorbance versus concentration (from 3 trials) (Fig. 2.7).

1

Styrene was dissolved in 100 mM phosphate-citrate buffer, pH 3.25. Since styrene
absorbance decreases with time because of its poor solubility in aqueous solutions, all
solutions with styrene were freshly prepared for each trial.

Figure 2.7. A plot of styrene concentration versus absorbance at 262 nm (average of 3
trials). Error bars represent standard deviation.
2.3 Results and discussion
2.3.1 The proton NMR study
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The chemical shifts of two beta protons of Cys 29 in the WT were observed at +39.5
ppm and -21.5 ppm, which are consistent with results reported by Wang et al. (183). The
signal of His Hε of HRP is located at -31.0 ppm, consistent with results reported previously
(223). The chemical shifts at +60.0 ppm and -28.5 ppm were assigned to His 29 Hδ and Hε
of the mutant enzyme, respectively. The difference in the location of Hδ signals in HRP
and C29H might be attributed to the differences in the orientation of the proximal His with
respect to the heme. Thus, the substitution of the proximal Cys in C29H CPO was
confirmed by 1H-NMR spectroscopy.

Figure 2.8. 600-MHz proton NMR spectra of cyanide complexes of HRP, WT and C29H
CPO in deuterated phosphate buffer, pH 5.9.
2.3.2 Circular dichroism of WT and variant CPO
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Circular dichroism spectroscopy was used to determine if substitution of Cys 29 with
a His had a significant effect on the secondary structure of CPO, which in turn might affect
the substrate affinity and enzymatic activity of the enzyme. Since the van der Waals volume
of a histidine (118 A3) is larger than that of a cysteine (86 A3) (224, 225), it is likely that
some perturbation of the mutant active site occurred which may affect the protein
secondary structure, possibly in the proximal helix region where the proximal ligand is
located. This, in turn, could affect the redox potential of the heme iron and biochemical
properties of the protein. Thus, cysteine ligation might be important for maintaining a
particular architecture of the active site necessary for catalytic diversity.
The secondary structures of the C29H and WT CPO were estimated using JASCO CD
spectrometer and CDSSTR (Fig. 2.9). For WT, alpha-helical and beta-sheet contents were
found to be 30% and 25%, respectively. For C29H, alpha-helices and beta-sheets were
estimated at 34% and 20%, respectively. The differences in the secondary structural
elements of the WT and the mutant are quite small and are unlikely to contribute
significantly to the functional differences of these two enzymes. However, possible
changes in the tertiary structure of the protein, especially proximal helix orientation (226),
could affect the redox potential and reactivity of C29H CPO.
Using CD spectroscopy, it is possible to determine if tertiary structural changes occur
upon mutation; however, this method is not specific enough to indicate the region where
the changes occur. In order to determine the locations and magnitude of the tertiary
structural changes, it would be necessary to solve crystal structure of the mutant and
compare it with that of the WT.
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Figure 2.9. CD spectra of 1.0 µM WT and C29H CPO in acetate buffer, pH 5.5.
2.3.3 UV-Visible spectroscopic properties of WT and C29H CPO
UV-Vis spectrophotometry was used to obtain a spectroscopic signature of CPO that
can provide useful information about the electronic, magnetic, and molecular structure of
the heme active center. The spectrum of WT CPO shows the Soret peak at 398 nm as well
as β, α, and charge transfer (CT) bands at 515, 545, and 650 nm, respectively (Fig. 2.10
and Table 2.5). The peaks at 515 and 650 nm are considered the high-spin markers
indicating that ferric WT CPO is in high-spin pentacoordinate form. The Soret band of
C29H is red shifted to 419 nm. The Q bands shifted as well to 540 and 570 nm indicating
that ferric C29H possesses low-spin heme that is coordinated to a sixth ligand, possibly
water or an amino acid in the distal active site. Furthermore, it has been proposed that the
relative intensities of the α and β bands can be an indication of how close in energy the a 2u
and a 1u orbitals of porphyrin are (179, Figs. 1.20 and 1.21).
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Figure 2.10. UV-Vis spectra of WT and C29H CPO in 25 mM phosphate buffer, pH 5.9.
Table 2.5. UV-Vis spectral properties of ferric WT and C29H CPO in phosphate buffer,
pH 5.9 (n.s.-no shoulder, s.s.-slight shoulder, l.i.-low intensity).
Protein

WT CPO
C29H

δ band

Soret

β band

α band

CT

(nm)

(nm)

(nm)

(nm)

(nm)

--

398 (n.s.)

515

550

650

354

419 (s.s.)

540

570

645 (l.i.)

If the two orbitals are very similar in energy, the α/β intensity ratio will be small. The α/β
intensity ratios of WT and C29H CPO suggest that a 2u and a 1u porphyrin orbitals in WT
are closer in energy than those in C29H mutant. In addition, the spectrum of C29H exhibits
a clear δ-band, which indicates that the heme iron is in a low spin. Moreover, the δ-band
was proposed to be a result of an electron cloud density around the heme, and hence can
be viewed as a sensor for the heme redox state (227).
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To investigate the pH influence on the structure of CPO, the absorption spectra of
both WT and C29H CPO in a phosphate buffer at different pH were obtained. It is well
known that WT CPO transforms from the active high-spin state to the inactive low-spin
form at alkaline pH (228). The pKa for the transition of the active WT CPO to the inactive
C420 form was determined to be 7.5 by Blanke et al. (228). It has been proposed that at
this pH, deprotonation of an amino acid in the active site results in further ionization of
other residues, which in turn induces a conformational change in the protein. Later, it has
been shown that this ionizable amino acid interacts with the heme iron. It is possible that
these interactions prevent ligand binding to the alkaline form since exogenous molecules
were shown to be unable to bind heme (228). Therefore, the inactivation of CPO might be
a result of its inability to bind H 2 O 2 , which is required for formation of the catalytic
species, Cpd I.
Wild-type CPO at neutral and acidic pH exists as a pentacoordinate high-spin form as
suggested by its UV-Visible spectrum (Fig. 2.11). At pH 8.0 and above, the heme iron state
changes to a low-spin as evident from the red shift of the Soret band and decrease in
absorbance at 515 and 650 nm (high spin markers). My results are consistent with
previously reported data and show that transition to the alkaline low-spin, hexacoordinate
form occurs between pH 7 and 8 (Fig. 2.11).
Different results are observed for C29H, which stays in a hexacoordinate, low-spin
state over a wide range of pH from very acidic to alkaline (Figs. 2.12 and 2.13). The
spectrum starts changing at pH 3.5. The intensity of the Soret band starts decreasing and a
new peak at around 400 nm is observed at pH 2.5 indicating transitioning from the low
spin species to the high spin form.
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Figure 2.11. UV-Vis absorption spectra of WT CPO in phosphate or phosphate-citrate
buffer at different pH.

Figure 2.12. UV-Vis absorption spectra of C29H CPO in phosphate or phosphate-citrate
buffer in the acidic pH range.
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Figure 2.13. UV-Vis absorption spectra of C29H CPO in phosphate-citrate buffer in basic
pH.
These spectroscopic results also suggest that the distal ligand, possibly water or an
amino acid, is very acidic with a low pKa. Even though it would be unusual for water to
have such a low pKa (below 3.5), it is possible that its interactions with heme result in a
pKa decrease.
2.3.4

CO binding to WT, C29H CPO, C29H/C79H, and C29H/C79H/C87H CPO
Binding of ligands to CPO depends on the size of the ligands and their pKa values.

Quite a few ligands were found to bind either to ferric or ferrous CPO. The ligands include
but are not limited to dioxygen, carbon monoxide, cyanide, pyridine, nitrate, nitrite,
thiocyanate, imidazole, organic isocyanides, and acetate (174, 219). In general, the binding
properties of CPO are similar to those of classical peroxidases. An exception is the binding
of carbon monoxide to ferrous CPO to produce an absorption peak at around 450 nm,
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similar to cytochromes P450. It has been postulated that thiolate ligation in P450s and CPO
enzymes is responsible for the observed unique 450-nm absorption. (9). Several studies
utilized heme Soret band absorption location for a ferrous protein-CO complex to
investigate the nature of the proximal ligand, stating that cysteine and histidine, upon
binding CO, would produce the peak near 450 nm and 420 nm, respectively (106, 196,
211-215).
My results with C29H CPO mutant shown in Figure 2.14 indicate that proximal
cysteine is not a prerequisite for the P450-like spectroscopic signature. The Soret band of
C29H upon reduction with sodium dithionite shifts from 419 nm to 407 nm. The spectrum
of C29H-CO complex (444 nm) is almost identical to that of the WT-CO (445 nm) although
the two enzymes have dramatically different proximal ligation (Fig. 2.15).

Figure 2.14. UV-Vis absorption spectra of ferric C29H, ferrous C29H, and ferrous C29HCO complex in phosphate buffer, pH 5.9.
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Figure 2.15. UV-Vis absorption spectra of ferrous WT-CO and C29H-CO at pH 5.9.
It can be argued that the absorption peak near 450 nm might be the result of the switch
of a His to a Cys ligation since CPO possesses two more cysteines (Fig 2.16). However,
even though such a switch is possible, it is unlikely because of the location of both Cys
residues in the helix C and their involvement in the formation of a disulfide bond. Swapping
of a proximal His in C29H CPO would require significant changes in the tertiary structure
of the protein and is very unlikely to occur.
To further investigate the possibility of the His to Cys switch, Cys 79 and Cys 87 were
also replaced with a His to create double and triple CPO mutants, C29H/C79H and
C29H/C79H/C87H. The spectra of mutant-CO complexes are shown in Figure 2.17. Both
mutant-CO absorb at 444 nm, similarly to the WT-CO. Since C29H/C79H/C87H mutant
is devoid of Cys, it cannot form a thiolate ligation. This finding supports my hypothesis
that thiolate is not a prerequisite for the P450-like spectroscopic signature of CPO.
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Figure 2.16. Locations of 3 cysteine residues in CPO. The following pdb file was used to
visualize CPO: 1CPO (75).

Figure 2.17. UV-Vis absorption
C29H/C79H/C87H-CO at pH 5.9.

spectra
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of

ferrous

C29H/C79H-CO

and

CN- binding to WT and C29H CPO

2.3.5

Cyanide is a known inhibitor of CPO and binds to other heme proteins as well. The
spectra of the WT CPO and its cyanide complex were obtained at pH 5.9. Since cyanide is
a very weak acid with a pKa of 9.14 (229), it binds to the ferric state of CPO in its
protonated form at pH 5.9. Upon binding cyanide, the spin state of CPO changes from high
to low as evident from the Soret band shift from 398 nm to 439 nm, the presence of the δband, and the disappearance of the CT band at 650 nm (Fig. 2.18, Table 2.6). After 15-min
incubation, the spectrum of the WT-CN complex remained the same.
The change in the spin state of iron occurs because of the rearrangement of electrons
in the molecular orbital of heme. According to the ligand-field theory originally developed
by Bethe (230) and later extended by others (231, 232), ligand electrons interact with
electrons in d orbitals of the iron (Fig. 1.21) resulting in a particular energy gap between
the d(xy), d(xz), d(yz) and d(x2-y2), d(z2) orbitals called the crystal-field splitting energy.
If this energy difference is larger than the electron pairing energy, then electrons fill up the
lower energy orbitals (d xy , d xz , d yz ) first resulting in a low spin state. If the crystal-field
splitting energy is smaller than the electron pairing energy, then electrons fill up empty d x2y2

and d z2 orbitals before pairing in d xy , d xz , and d yz orbitals, resulting in a high spin state.

Since cyanide is a strong field ligand, its binding to iron leads to a high crystal-field
splitting energy in d orbitals resulting in a low spin heme.
Slightly different behavior is observed for the C29H-CN complex, the Soret peak of
which shifts with time from 436 nm to 424 nm, in contrast to the unchanged WT-CN Soret
absorption (Fig. 2.19). This indicates that cyanide competes with another axial ligand,
possibly water, and has a lower affinity for the mutant than for the WT.
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Figure 2.18. UV-Vis spectra of ferric WT and WT-CN in phosphate buffer, pH 5.9.

Figure 2.19. UV-Vis spectra of ferric C29H and C29H-CN in phosphate buffer, pH 5.9.
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Table 2.6. UV-Vis spectral properties of ferric WT and C29H CPO and their cyanide
complexes at pH 5.9.
δ band
(nm)

Soret
(nm)

β band
(nm)

α band
(nm)

CT
(nm)

WT CPO

--

398

515

550

650

WT-CN

364

439

--

564

--

C29H CPO

354

419

540

570

645

C29H-CN

364

436→424

--

558

--

Protein

2.3.6 Catalytic properties of WT and C29H CPO
To investigate the effect of proximal ligand substitution on the catalytic capabilities
of CPO, the activities of C29H and WT were measured in 4 different assays: chlorination
of MCD, dismutation of H 2 O 2 , epoxidation of styrene, and peroxidation of ABTS (Figs.
2.20-2.23). C29H CPO showed a 10-fold and more than 50-fold increase in epoxidation
(pH 4.5) and peroxidation (pH 4.5) rates, respectively, while essentially abolishing
dismutation (pH 4.5) activity. In addition, the chlorination (pH 2.75) activity of the mutant
was only about 0.5% of the original activity of CPO (Fig. 2.24).
Catalysis of heme proteins is generally influenced by such factors as heme iron redox
potential, bond length between iron and proximal ligand, active site polarity, and
accessibility of the heme to substrates. Inability of C29H to carry out chlorination and
dismutation reactions could be caused by the change in the redox potential of iron (233).
Since thiolate ligation provides a stronger push than less electronegative imidazole,
the substitution of Cys with a His is expected to increase the redox potential of the heme
iron (234). However, a mere substitution of a proximal ligand for a less electronegative
residue does not necessarily result in redox potential increase since multiple factors
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determine activity. For example, C357H P450cam loses its oxygenase activity upon
substitution of Cys 357 with a His (208, 209) while the activity of myoglobin is increased
when proximal His is replaced with a Cys (196, 196).

Figure 2.20. Chlorination of MCD to DCD by WT and C29H CPO at pH 2.75.

Figure 2.21. Dismutation of H 2 O 2 by WT and C29H CPO at pH 4.5.
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Figure 2.22. Epoxidation of styrene by WT and C29H CPO at pH 4.5.

Figure 2.23. ABTS peroxidation by WT and C29H CPO at pH 4.5.
My results on C29H catalysis suggest a decrease in the redox potential of the mutant,
which in turn would lead to changes in the distal axial ligand pKa, important for the
formation of the active catalytic intermediates (Cpd I, Cpd II, Cpd X) (109, 204). Redox
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potential and basicity of the distal ligand have an inverse relationship (235, 236), so
increase in the ligand basicity would be expected. A more basic distal ligand is easier to
protonate, which partly explains the increase in peroxidation activity, which requires Cpd
II formation. It is possible that WT-Cpd II is harder to protonate at pH 4.5, resulting in
lower activity than in the mutant, whose Cpd II pKa is higher. Similarly, lack of
dismutation activity can be explained by changes in a substrate pKa that might prevent
binding of hydrogen peroxide to Cpd I.

Figure 2.24. Relative activities of WT (RZ=1.3-1.5) and C29H CPO (RZ=1.2-1.5) in
chlorination (pH 2.75), epoxidation (pH 4.5), dismutation (pH 4.5), and peroxidation (pH
4.5) assays.
The lack of dismutation activity in the mutant is expected to contribute to the increase
in peroxidation and epoxidation rates, since there is no depletion of Cpd I and oxidizing
agent (peroxide) via the dismutation pathway. Another possible contribution to the increase
in epoxidation activity is better heme center accessibility by substrate, which is important
for two-electron oxidations by heme enzymes (237). The astounding increase in ABTS
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oxidation rates could be a result of perturbations in the active site affecting the heme-edge
accessibility required for one-electron oxidations (29). Similar observations were made in
cytochrome P450 by Auclair et al., where the Cys 357→His mutation resulted in a novel
peroxidase activity of the enzyme (30). My results indicate that thiolate ligation is required
for dismutation and chlorination activities of CPO, but is not important for peroxidation
and epoxidation reactions.
2.3.7 pH profiles of catalytic activities of WT and C29H CPO
Catalytic properties of CPO are highly pH dependent. To investigate how pH affects
reaction rates of both WT and C29H CPO, four assays discussed above were performed at
various pH. No significant chlorination or dismutation activities were observed for C29H
at any pH checked (Figs. 2.25 and 2.26). As discussed in the previous section, C29H may
be unable to form the protonated Cpd X and Cpd I-peroxide species required for
chlorination and dismutation reactions, respectively.
Interestingly, C29H maintained both epoxidase and peroxidase activities over a much
wider pH range than the WT (Figs. 2.27 and 2.28). The rates of the epoxidation reaction
catalyzed by WT CPO do not fluctuate significantly over the entire active pH range,
suggesting little influence of pH on the epoxidation activity of the WT. However, a clear
optimum of pH 4.5 is observed for C29H CPO. Such a pH profile is consistent with the
fact that abolishing dismutation activity should contribute to the increase in epoxidation,
and since the highest dismutation activity of the WT is at pH 4.5, the largest increase is
observed at that particular pH. Alternatively, epoxidation reactions catalyzed by WT and
C29H CPO might proceed via a dual pathway involving different active intermediates, as
has been suggested for the epoxidations catalyzed by CYPs (149).
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Figure 2.25. pH profile of chlorination activities of WT and C29H CPO (some error bars
are smaller than point size and are not visible on the graph).

Figure 2.26. pH profile of dismutation activities of WT and C29H CPO (some error bars
are smaller than point size and are not visible on the graph).
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Figure 2.27. pH profile of epoxidation activities of WT and C29H CPO (some error bars
are smaller than point size and are not visible on the graph).
In the peroxidation assay, the WT CPO reaction rates are significantly reduced above
pH 3.5 while the mutant remains active even at pH 5.5. Since Cpd I is the active species in
the catalytic cycle of CPO, C29H must be able to form this intermediate at both acidic and
neutral pH in contrast to the WT, which loses activity at neutral pH because of the
formation of the inactive alkaline form (228). C29H-Cpd I formation at higher pH can be
explained by the fact that the mutant does not undergo alkaline transition near neutral pH
as observed in the WT. In addition, if Cpd II, the second intermediate in the peroxidation
pathway, is indeed an iron(IV)-hydroxide intermediate as suggested by Green and Lai
(107), then its pKa would affect the optimal pH. WT is active in the peroxidation assay at
very acidic pH, suggesting that the pKa of WT-Cpd II is below 3.25. In C29H, the pKa of
Cpd II might be significantly higher (around 4-4.5), and that would result in the formation
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of the active protonated Cpd II at higher pH. For this reason, it is understandable that C29H
CPO is able to carry out peroxidation over a wider pH range than the WT.

Figure 2.28. pH profile of peroxidation activities of WT and C29H CPO (some error bars
are smaller than point size and are not visible on the graph).
Overall, this study suggests that thiolate ligation plays an important role in both the
structure and catalysis of CPO, and substitution with a histidine affects the biochemical
properties of the enzyme not only because of the different natures of the ligands but also
because of possible changes in the protein architecture. Although, secondary structures of
the WT and C29H did not differ significantly as measured by CD, it is possible that tertiary
changes have affected the heme environment (for example, the high to low spin conversion
and the change in the heme coordination), which is important for the enzyme function.
Furthermore, my results on CO binding to single, double, and triple Cys mutants have
shown that proximal thiolate ligation is not required for P450-type spectroscopic properties
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of CPO. However, proximal thiolate is important for binding of anionic ligands.
2.4 Conclusion
After years of research on heme catalysis, there is still an ongoing debate about the
importance of the proximal thiolate ligation in heme proteins. Several proximal ligand
mutant heme proteins were engineered and characterized by different researchers with
varying success, and no consensus on the role of proximal Cys has been achieved. In this
study, I employed rational design to investigate the role of Cys 29 in biochemical and
physical properties of CPO. Three CPO mutants (C29H, C29H/C79H, C29H/C79H/C87H)
with proximal imidazole ligation were constructed using site-directed mutagenesis and
characterized using various spectroscopic techniques. My study has demonstrated that
proximal thiolate ligation is important for the catalytic diversity of CPO, particularly for
chlorination and dismutation activities. However, it is not essential for peroxidation and
epoxidation. Furthermore, I discovered that thiolate ligation is not a prerequisite for the
P450-like spectroscopic signature of CPO. This finding is quite unexpected since it has
been proposed that proximal Cys ligation in CYPs and CPO is responsible for the unique
optical property of these proteins. My work has provided solid support for the importance
of thiolate ligation in heme catalysis and has opened new avenues for further exploration
of factors defining biochemical properties of heme enzymes.
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CHAPTER III.
EFFECTS OF HYDROGEN BOND NETWORK IN THE PROXIMAL HELIX ON
THE SPECTROSCOPIC PROPERTIES OF CHLOROPEROXIDASE
3.1 Background
Despite extensive research performed on various heme-thiolate enzymes including
CYPs, CPO, and NO synthase, much remains to be explored about mechanisms influencing
their catalysis (28, 31-33). Various spectroscopic techniques along with site-directed
mutagenesis are utilized to obtain information about how particular protein structural
features influence its function. It has been shown that the nature of the proximal and distal
ligands as well as hydrogen bonding networks in the active site play important roles in
defining the biochemical and physical properties of heme proteins. In general, the redox
potentials of heme proteins decrease with more electronegative proximal ligands creating
the following trend: imidazole > thiolate > phenolate (48). However, proximal imidazole
ligation does not guarantee higher redox potential since the overall architecture of the
active site fine-tunes reactivity. For example, the redox potentials of CPO, a heme thiolate
protein, and HRP, a heme imidazolate enzyme, are -140 mV and -278 mV at pH 7,
respectively (48), which implicates the critical role of hydrogen bonding networks within
the active site in determining the structural and functional properties of heme proteins.
In the proximal site of CPO, there are 2 H-bonds between Cys 29 and the amide groups
of Ala 31 and Leu 32 situated at the N-terminus of helix A (98). These H-bonds prevent
protonation of the thiolate, which results in inactivation of CPO, and decrease its negative
charge thus contributing to the increase of the iron redox potential (101, 102). In addition
to these H-bonds, there is another H-bonding network formed by Arg 26-Asn 37 and Ala

74

27-Asn 33, which is a part of helix A of CPO (Fig. 3.1). The effects of this H-bonding
network on the spectroscopic and catalytic properties of CPO are unknown.

Figure 3.1. Hydrogen bond network in the proximal helix of CPO.
In this study, I explored how the partial or complete removal of the aforementioned
H-bonds affected spectroscopic properties of CPO. I replaced Arg 26 and Asn 33 with Ala
to disrupt H-bonding and characterized R26A, N33A, and R26A/N33A CPO using UVVis spectrophotometry and CD spectroscopy.
Electronic absorption spectroscopy, or UV-Vis spectrophotometry, is often used to
probe the heme environment and its electronic structure, i. e., the coordination and spin
state of the heme iron. As described in the introduction, a typical heme protein absorption
spectrum (Fig. 18) (177) displays the Soret, δ, and Q (α, β, CT) bands that result from
electronic transitions in the porphyrin (Fig. 19) (178). Shifts and shapes of these bands can
provide information about the spin and coordination state of the heme iron. The Soret and
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Q bands at lower wavelengths as well as a charge transfer band at around 650 nm indicate
that the heme iron is in a high spin state. Furthermore, the intensities of the α and β bands
relative to each other can provide information about relative energies of the a 2u and a 1u
orbitals of the porphyrin. For example, if both orbitals are very similar in energy, the α/β
intensity ratio will be small. On the contrary, if the a 2u and a 1u orbitals have different
energies, the α/β intensity ratio will be large (179).
Other interactions that can be observed with UV-Vis spectrophotometry include
porphyrin-iron and iron-ligand interactions. For example, ferrous iron has filled d π orbitals
(d6), and electrons in d π (d(xz), d(yz)) orbitals of the iron strongly interact with electrons
in porphyrin π* (a 1u ) orbital. Such strong interactions result in a larger separation between
porphyrin π and π* (a 2u and a 1u ) orbitals causing the hypsochromic (blue) shifts in
electronic spectra (Fig. 20). In contrast, in metalloporphyrins with closed d-shells (d0 or
d10), the d π metal orbitals have little effect on the π to π* energy separation in porphyrin
electronic spectra because of their low energy (180). Ligand-binding studies can provide
useful information about the environment of the active site and insights about catalytic
mechanisms. Frequently, binding of a ligand in the heme distal side causes changes of the
iron spin state. For example, CPO, whose resting state is a five-coordinate high spin form,
changes to the low spin upon binding cyanide.
Circular dichroism is often used to investigate protein secondary and tertiary
structures and to monitor structural changes in mutant proteins or protein-ligand
complexes. Several algorithms are available for estimation of alpha-helical, beta-sheet, and
random coil contents and include CONTINLL (184, 185), SELCON3 (186, 187), CDSSTR
(188-190), VARSLC (188, 189), and K2D (191). One method might be more suitable than
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others for the analysis of a particular protein since the aforementioned algorithms utilize
different protein reference sets. For example, when analyzing globins, it is prudent to
choose a program that has more globular proteins in its reference set so that better
prediction of the protein structure can be made. In the case of CPO, I found that CDSSTR
program produced more accurate estimations of secondary structures, especially for alphahelices that were in a better agreement with the published crystal structure of CPO.
Circular dichroism can provide useful information about integrity of protein domains
expressed separately, protein stability under changing conditions, and structural alterations
in mutants or upon ligand binding. For heme proteins, CD may also reflect changes in the
environment of the heme (192). For example, heme absorbs strongly at around 410 nm and
has additional signals between 500 and 600 nm. Thus, changes in those regions would
indicate changes in the heme active site (238).
In this study, I utilized the techniques described above to probe the roles of proximal
H-bonds in CPO. My results have shown that the H-bond network of the proximal helix is
important not only for maintaining a local active site environment but also for the overall
organization of CPO that in turn affects ligand binding.
3.2 Experimental procedures
All chemicals and materials used are the same as described in section 2.2.1.
3.2.1 Construction of R26A, N33A, and R26A/N33A CPO genes
To investigate the structural and spectroscopic roles of the hydrogen bond network in
the proximal helix of CPO (Arg 26-Asn 37 and Ala 27-Asn 33), two single (R26A, N33A)
mutants and one double (R26A/N33A) mutant were created. Mutations were introduced
into the pCPO3.I – AmdS (Fig. 2.1) via PCR amplification using the QuikChange II XL
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site-directed mutagenesis kit. Polymerase chain reaction was carried out as described in
section 2.2.2. The following primers were used to introduce the R26A, N33A, and
R26A/N33A mutations:
Coding strain – R26A primer 1
5’- CTACCGACTCTGCTGCTCCTTGCCCAGCTCTGAACG - 3’
Non-coding strain – R26A primer 2
5’- GAGCTGGGCAAGGAGCAGCAGAGTCGGTAGGACCTG - 3’
Coding strain – N33A primer 1
5’- CTTGCCCAGCTCTGGCCGCTCTTGCCAACCACGGTT - 3’
Non-coding strain – N33A primer 2
5’- GTTGGCAAGAGCGGCCAGAGCTGGGCAAGGAGCACGAG - 3’
Coding strain – R26A/N33A primer 1
5’- GTCCTACCGACTCTGCTGCTCCTTGCCCAGCTCTGG-3’
Non-coding strain – R26A/N33A primer 2
5’- CAAGGAGCAGCAGAGTCGGTAGGACCTGGGGCGAC -3’
Polymerase chain reaction products were amplified in DH5-α E. Coli. Mutations were
confirmed by DNA sequencing (Figs. 3.2-3.4).

Figure 3.2. R26A pCPO sequencing results.
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Figure 3.3. N33A pCPO sequencing results.

Figure 3.4. R26A/N33A pCPO sequencing results.
3.2.2 Transformation of Aspergillus niger with mutant pCPO, expression and
purification of R26A, N33A, and R26A/N33A CPO
Transformation of A. niger with mutant pCPO was performed as described in section
2.2.3. Expression and purification of mutant CPO was carried out as described in section
2.2.4 with some modifications. Expression of R26A CPO proved to be quite difficult. Since
R26A had low expression levels, 72 L of culture were grown. After purification, the protein
contained both halo- and apoprotein. Hoping to improve incorporation of heme into the
R26A mutant, I added hemin to cultures grown at 25°C for three days to a final
concentration of either 25 µM or 50µM.
During purification on DEAE column, R26A CPO eluted at approximately 20% 0.5
M NaCl. Fractions with RZ values (A 420 /A 280 ) above 0.5 were used for further purification
by size exclusion chromatography (Fig. 3.5). Fractions with RZ values between 1.0 – 1.1
were used in subsequent studies. Purity of the mutant CPO was assessed by SDS-PAGE
(Figs. 3.6 and 3.7).
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Figure 3.5. R26A CPO sample loaded on a gel filtration column.

Figure 3.6. SDS-PAGE. WT and R26A CPO. Lanes 1 and 2 – R26A, lane 3 – WT CPO.
Expression of the other two mutants, N33A and R26A/N33A, produced better yields,
thus 36-L and 30-L cultures were grown, respectively. During ion-exchange
chromatography, N33A and R26A/N33A CPO eluted at approximately 30% and 20% 0.5
M NaCl, respectively. Fractions with RZ values (A 420 /A 280 ) above 0.6 and 0.5,
respectively, were used for further purification by size exclusion chromatography.
Fractions with RZ values between 1.0 – 1.1 were used in subsequent studies. Purity of the
mutant CPO was assessed by SDS-PAGE.
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Figure 3.7. SDS-PAGE. N33A CPO. WT – wild type CPO, 2-6 – N33A fractions from gel
filtration, M – marker.
3.2.3 UV-Visible spectrophotometry
UV-Visible spectrophotometry was used to investigate heme electronic configuration
and ligand-binding properties of the mutants lacking hydrogen bonds in the proximal helix
A of CPO. The procedures are described in sections 2.2.5.3 and 2.2.6 with the following
modifications. The effect of pH study was performed at pH 2.4, 3.5, 6.0, 8.0, 10.0. Excess
cyanide (100 mM) binding was performed at pH 6.0 and pH 12.0. Titrations of CPO (10800 μM for WT and 1-10 mM for mutants) with CN- were performed in a phosphate buffer,
pH 6.0. The cyanide dissociation constant (Kd), which is an inverse of a binding constant
(K), was calculated from the following equation (239):
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,
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where ∆𝐴𝐴 is the maximum absorbance difference, ∆𝐴𝐴∞ is the change in absorbance of
CPO-CN complete formation, K is a binding affinity constant, and [S] is the concentration

of free CN-. The Hill equation (240) was used to determine the stoichiometry of CNbinding to mutants. In Eq. 3.2, h is the number of binding sites:
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(3.2)

3.2.4 CD spectroscopy
Circular dichroism spectroscopy was used to probe possible changes in secondary and
tertiary structures of mutant CPOs as a result of the proximal helix hydrogen bond network
disruption. Procedures for the secondary CD are described in section 2.2.5.2. As for the
tertiary CD, the spectra of 16 µM R26A, 35 µM N33A, 11 µM R26A/N33A, and
corresponding concentrations of WT CPO in phosphate buffer, pH 5.9 were collected in
the 250-600 nm range at room temperature using 1-cm quartz cuvettes. Three spectra were
averaged for each protein.
3.3 Results and discussion
3.3.1 Secondary and tertiary CD spectroscopy of WT and mutant CPO
Asn 33 and Asn 37 are hydrogen bonded to Ala 27 and Arg 26, respectively, and are
located in proximal helix A. Helix A also contains Cys 29 coordinated to the heme, thus
deletion of the H-bonds in either of the aforementioned residue pairs might affect both the
local environment of the heme and the alpha-helical structure of CPO. Structural
alterations, in turn, could influence catalytic and binding properties of CPO. Removal of
all H-bonds in the proximal helix is expected to have a larger effect on the helix A position,
possibly influencing its flexibility, which also might affect the proximal site environment.
The secondary CD spectra of the single amino acid mutants, R26A and N33A, show
only slight changes while the CD spectrum of R26A/N33A is significantly different from
that of the WT (Fig. 3.8). As estimated by CDSSTR, the alpha helical structures of WT,
R26A, N33A, and R26A/N33A are 31%, 29%, 30%, and 51%, respectively. The betasheets have been estimated to be at 25%, 23%, 22%, and 18%, respectively. Disruption of
the pair of hydrogen bonds between either R26-N37 or A27-N33 does not seem to
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significantly change secondary structure of CPO. However, removal of both pairs of Hbonds results in a noticeable alteration of the alpha-helix (20%-increase). Since the amino
acids directly adjacent to the proximal helix are disordered, it is possible that the absence
of the H-bonds promotes organization of this region into an alpha helix extending helix A
affecting its rigidity. Such changes in the proximal helix would affect the local heme
environment since Cys 29, the heme ligand, is situated in this helix.

Figure 3.8. Secondary CD of 1.0 µM WT and mutant CPO in phosphate buffer, pH 5.9.
To investigate whether mutations in the active site of CPO affect its tertiary structure,
CD spectra of the WT and the mutants have been taken in the 250-600 nm region (Figs.
11-13). All mutants exhibit significant tertiary spectral changes in both aromatic and heme
regions. Aromatic residues (Phe, Trp, Tyr) as well as disulfide bonds produce signals
between 250 and 330 nm. Trp, Tyr, and Phe absorb at around 290 nm, 280 nm, and 260270 nm, respectively (241). In addition, the disulfide bond band extends from about 330

83

nm to its maximum at around 260 nm and is usually weak. However, its intensity depends
on C-S-S bond angle, dihedral angle of the disulfide bond, and effects of surrounding
groups (238). Chloroperoxidase has 18 Phe, 5 Trp, and 11 Tyr in its primary structure.
Thus the broad positive signal in 275-300 nm region is likely produced by Trp and Tyr
residues. The negative band at around 265 nm can be a combination of absorptions arising
from Phe and a disulfide bond between Cys 79 and Cys 87. All three mutants produce
negative signals in aromatic region, which indicate changes in the rigidity or environment
of aromatic residues and possibly of the disulfide bond region.
The region between 400 – 650 nm provides information about the heme environment.
Heme absorbs at around 350 nm (delta band), 410 nm (Soret), and between 500-650 nm
(Q bands). In the CD spectrum of WT CPO, the heme group has strong absorptions at 428
nm (Soret) and 545 (Q band) nm. Additional weak negative signals are located at 372 nm
and 480 nm. Spectra of the mutants are markedly different from that of the WT (Figs. 3.93.11 and Table 3.1). The signals described above for the WT disappear in R26A with the
exception of a weak absorption at around 480 nm. There is a broad negative peak in 500600 nm region with two maxima at 561 nm and 572 nm. The CD spectrum of R26A
suggests that the heme environment in R26A is quite different from that in the WT. In
addition, the absence of the Soret signal may reflect poor incorporation of the heme into
the R26A mutant, which is also supported by the lower RZ value. Furthermore, the Soret
band in R26A UV-Vis spectrum decreases significantly within 1-2 months of protein
expression, indicating low mutant stability. A very weak signal at around 344-350 nm
(delta band) is present in the spectra of all three mutants, which indicates that the
electronegative environment of the heme has changed in H-bond deletion mutants.
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Figure 3.9. Tertiary CD spectra of 16 µM WT and R26A CPO at pH 5.9.

Figure 3.10. Tertiary CD spectra of 35 µM WT and N33A CPO at pH 5.9.
In N33A and R26A/N33A, the Soret bands are observed at 424 nm and 420 nm,
respectively, and are broader than that of the WT with a shoulder at around 400 nm.
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Figure 3.11 Tertiary CD spectra of 11 µM WT and R26A-N33A CPO in phosphate buffer,
pH 5.9.
Table 3.1. CD spectral properties of ferric WT and mutant CPO in phosphate buffer, pH
5.9 in the heme region ((+), (-), (s) indicate positive and negative signals, and a shoulder
in a band, respectively).
δ band (nm)

Soret (nm)

CT band
(nm)

Q bands (nm)

WT CPO

372(-)

428(--)

480(-)

545(++)

R26A CPO

344(-)

--

481(-)

561(--), 572(--)

N33A CPO

350(-)

424(--) (s)

--

547(+), 559(-), 579(-)

R26A/N33A
CPO

345(-)

420(--) (s)

--

575(--), 580(--)

Protein

In the spectra of both N33A and R26A/N33A mutants, there are no signals at 370 nm and
480 nm; however, three and two Q bands are present, respectively. These observations
suggest that the heme active centers in those two mutants are similar to each other but
different from that in the WT.
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Overall, the CD results indicate that the largest secondary structural changes have
occurred in the R26A/N33A affecting alpha-helical content, while the heme environment
has been altered in all three mutants. To further investigate the properties of the heme, UVVis spectroscopy was employed, and the results are discussed in the following section.
3.3.2 UV-Vis spectroscopic properties of WT, R26A, N33A, and R26A/N33A CPO
As mentioned before, heme proteins possess a spectroscopic signature in the UVVisible region that can provide useful information about the electronic and molecular
structure of the heme active site. The spectrum of WT CPO shows the Soret band at 398
nm as well as β, α, and CT signals at 515, 545, and 650 nm, respectively (Figs. 14, 15).
The β and α bands are not well-resolved indicating greater mixing of the a 2u and a 1u
porphyrin orbitals. The high spin markers at 515 and 650 nm indicate that the heme iron is
in the high-spin pentacoordinate form. The Soret and Q bands of the mutants are red-shifted
and their positions are consistent with mutants having a low spin heme (Fig. 3.12 and Table
3.2).
Table 3.2. UV-Vis spectral properties of ferric WT and mutant CPO at pH 5.9 (s-shoulder,
n.s.- no shoulder, s.s.- slight shoulder).
δ band
(nm)

Soret
(nm)

β band
(nm)

α band
(nm)

CT
(nm)

--

398 (n.s.)

515

550

650

R26A CPO

354

418 (s)

540

568

644 (low)

N33A CPO

356

420 (n.s.)

540

575

--

R26A/N33A CPO

356

421 (s.s.)

540

575

644 (low)

Protein
WT CPO
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Figure 3.12. UV-Vis spectra of WT, R26A, N33A, and R26A/N33A CPO in 25 mM
phosphate buffer, pH 5.9.
The Q bands at around 540 nm and 570 nm in the mutant spectra indicate that ferric
mutants possess the hexacoordinate low-spin heme with water or an amino acid as a distal
ligand. R26A and R26A/N33A show very low absorption peaks at 644 nm, which suggests
that a small fraction of the protein might be a high-spin state. Furthermore, the α/β band
intensity ratio in WT spectrum is similar to that in R26A and lower than that in N33A and
R26A/N33A mutant spectra (Fig. 15). These ratios suggest that a 2u and a 1u porphyrin
orbitals (Figs. 1.20 and 1.21) in WT and R26A might be closer in energy than those in
N33A and R26A/N33A. In addition, the spectra of all mutants possess a clear δ-band,
which is also an indication of a low-spin heme.
To investigate structural changes in CPO at acidic and alkaline pH, the UV-Vis
spectra of both WT and mutants were taken at 2.4-10.0 pH range. Wild-type CPO remains
in a high spin penta-coordinate form in the acidic pH range, and converts from the active
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high-spin state to the inactive low-spin form at pH above 7.5 (220). It has been suggested
that at this pH, an amino acid in the active site of CPO is deprotonated, which results in
further ionization of other residues. The ionizable amino acid interacts with the heme iron,
which influences its pKa. It was also shown that binding of exogenous ligands to the
alkaline form of CPO is difficult or impossible (228). These observations indicate that
interactions of the ionizable residue with the heme might prevent binding of H 2 O 2 to heme
required for Cpd I formation, thus resulting in inactivation of CPO.
My spectral results are consistent with those reported previously and show that WT
CPO is stable even at very acidic pH (2.4) and its transition to the alkaline low-spin
hexacoordinate form occurs between pH 7 and 8 (Fig. 2.11). Different UV-Vis spectra have
been obtained for CPO H-bond mutants, which primarily exist in the low-spin
hexacoordinate state in a broad pH range, except R26A (Figs. 3.13-3.17). The spectrum of
N33A at pH 2.4 has a broad peak at around 380 nm without any Q bands present. Such a
spectrum resembles that of free heme in aqueous solution, suggesting protein unfolding
and exposure of heme to the solvent (242). Another transition occurs above pH 9.0 (Fig.
3.14), which is likely because of the deprotonation of one or more critical residues with an
apparent pKa near 10. It is also possible that partial denaturation of the protein occurs
because of the high alkalinity. A similar transition is also observed for R26A/N33A at
pH10.0 (Fig. 3.16). However, different results are obtained at acidic pH. The shape of the
Soret band in R26A/N33A at pH 2.4 suggests that the transition from the low spin has not
completely occurred and the double mutant has higher stability at pH 2.4 than N33A (Fig.
3.15). A shoulder at around 400 nm emerging from the Soret band and a high-spin marker
at around 650 nm indicate the mixed spin state of R26A/N33A.
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Figure 3.13. UV-Vis absorption spectra of N33A CPO in the acidic pH range.

Figure 3.14. UV-Vis absorption spectra of N33A CPO in basic pH.
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Figure 3.15. UV-Vis absorption spectra of R26A/N33A CPO in the acidic pH range.

Figure 3.16. UV-Vis absorption spectra of R26A/N33A CPO in basic pH.
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Figure 3.17. UV-Vis absorption spectra of R26A CPO at various pH.
It should be noted that out of all CPO mutants created during my research, R26A had
the lowest stability and it was the most difficult to express. Its decreased stability is evident
from the spectral study with varying pH (fig. 3.17). The spectrum of R26A already starts
changing at pH 5.0 in the acidic pH range, suggesting a conformational change involving
protonation of a residue with a pKa around 5. Similar spectral changes occur at pH 8.0,
indicating a second transition possibly involving deprotonation of another residue with a
higher pKa.
3.3.3 Ligand binding to WT and R26A, N33A, and R26A/N33A CPO
The ligand-binding properties of CPO mutants can be used to further probe their active
site structures. Although WT CPO spectroscopic properties and heme iron coordination are
similar to those in P450s, WT CPO possesses a peroxidase-like active site heme
environment because its ligand-binding properties resemble those of classical peroxidases
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(174). The size and pKa of exogenous ligands determine how they bind to CPO. Weakly
acidic ligands bind in a protonated state and exhibit decreased affinities above their pKa
(for example, cyanide, pKa 9.14). Strongly acidic ligands bind in a deprotonated form and
exhibit larger variations in affinities especially at more acidic and alkaline pH (for example,
thiocyanate, pKa -1.9). Affinities of neutral ligands do not depend on pH (for example,
CO) (174). In this study, the binding of CO and CN- to the WT and mutant CPO was
investigated. Since CO is a neutral ligand whose affinity does not depend on pH, its binding
to the ferrous CPO was monitored at a single pH of 6.0. In contrast, weakly acidic CNshould exhibit lower affinity above pH 9.14 and, therefore, its binding to the ferric CPO
was investigated at pH 6.0 and pH 12.0.
3.3.3.1 CO binding to WT and mutant CPO
The Soret bands of the WT and mutant CPOs upon reduction with sodium dithionite
shift to around 408 nm (Figs. 3.18-3.21 and Table 3.3).
Table 3.3. Spectral properties of ferrous WT, R26A, N33A, and R26A/N33A CPO and
their CO complexes.
δ band (nm)

Soret (nm)

Q band (nm)

WT CPO

--

408

550

WT-CO

--

445

550

R26A

--

408

551

R26A-CO

--

444

551

N33A

--

407

551

358

443

551

--

408

550

357

444

550

Protein

N33A-CO
R26A/N33A
R26A/N33A-CO
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Figure 3.18. UV-Vis absorption spectra of ferric R26A, ferrous R26A, and ferrous
R26A-CO complex in phosphate buffer, pH 5.9.

Figure 3.19. UV-Vis absorption spectra of ferric N33A, ferrous N33A, and ferrous N33ACO complex in phosphate buffer, pH 5.9.
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Figure 3.20. UV-Vis absorption spectra of ferric R26A/N33A, ferrous R26A/N33A, and
ferrous R26A/N33A-CO complex in phosphate buffer, pH 5.9.

Figure 3.21. Comparison of UV-Vis absorption spectra of ferrous mutant-CO complexes
in phosphate buffer, pH 5.9.
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The overall shape of WT, R26A, N33A, and R26A/N33A CPO spectra resemble each other
suggesting similar ferrous CPO states in both the WT and mutants. The Soret absorption
of the ferrous mutant CPO-CO complexes (443-444 nm) is almost identical to that of the
ferrous WT-CO (445 nm) (Fig. 3.21). Interestingly, N33A-CO and R26A/N33A-CO
complexes show the delta band at 358 nm and 357 nm, respectively, with the first mutant
having more defined peak (Fig. 3.21). The presence of delta band indicates differences in
the electronegative environment of the heme in these two mutants, which can influence the
catalytic properties of CPO (discussed in chapter IV).
3.3.3.2 Cyanide binding to WT and mutant CPO
To examine mutant ligand-binding properties further, the UV-Vis spectra of ferric
WT and mutant cyanide complexes were obtained at pH 6.0 and pH 12.0 in the presence
of CN- excess (100 mM). The spectra were recorded upon addition of cyanide (0 min) and
after incubation of the sample for 1 hour at room temperature (60 min) (Figs. 3.22-3.25).
First, I will discuss results obtained at acidic pH. The absorption spectra of the ferric WTCN and mutant-CN resemble each other, exhibiting delta, Soret, and alpha bands. The
initial Soret position in the mutant-CN spectra is similar to that of the WT-CN (Table 3.4).
However, after a 1-hour incubation, mutant Soret bands have shifted to slightly different
locations with N33A-CN Soret blue-shifted the most (10 nm) while R26A and R26A/N33A
Soret bands blue-shifted only 4 nm and 2 nm, respectively. The spectrum of the ferric WTCN remained the same after 1 hour, indicating stronger CN- binding to the WT. To address
the question of whether CN- affinity is higher for the WT CPO than for the mutants, both
WT and mutant CPOs were titrated with potassium cyanide at pH 6.0 to determine cyanide
dissociation constant.
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Figure 3.22. Cyanide (100 mM) binding to WT CPO in phosphate buffer, pH 6.0.

Figure 3.23. Cyanide (100 mM) binding to R26A CPO in phosphate buffer, pH 6.0.
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Figure 3.24. Cyanide (100 mM) binding to N33A CPO in phosphate buffer, pH 6.0.

Figure 3.25. Cyanide (100 mM) binding to R26A/N33A CPO in phosphate buffer, pH 6.0.
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Since the pre-requisite for using Eq. 3.1 to determine Kd is titrations with excess
ligand, 1-10 mM (for mutants) or 2-10 mM (for WT) cyanide was added to protein
solutions (3-8 μM) in titration studies. Upon addition of 2 mM CN- to the WT CPO (red
spectrum), the Soret band shifted from 398 nm to 439 nm (Fig. 3.26, A). Upon gradual
increase of CN- concentration, the Soret peak has remained at 439 nm while absorption has
slightly increased. The shapes of other WT-CN spectra (4-10 mM CN-) are essentially
identical, and there is no isosbestic point formed by these spectra indicating the presence
of a single species in the solution at higher ligand concentrations. The spectrum of WT
CPO after addition of 2 mM CN- (red) has a slightly different shape, and it possesses an
isosbestic point (~427 nm) with spectra taken at higher CN- concentrations. This isosbestic
point can be explained by the presence of the equilibrium between uncomplexed WT and
WT-CN upon initial addition of CN-. Once the concentration of the ligand is increased, the
equilibrium shifts to WT-CN side, and no further changes in the WT-CN spectra are
observed. Since the shift of the Soret band is observed upon addition of 2 mM CN-, WT
has been titrated with 10-800 μM cyanide to observe gradual changes in the WT spectrum.
However, at these cyanide concentrations the protein to ligand ratio is smaller with the
highest being approximately 1:100, which introduces larger error when using Eq. 3.1 for
Kd determination.
Upon addition of lower concentrations of CN- (10-800 μM) to the WT CPO, the
intensity of the Soret band at 398 nm has gradually decreased while a new peak has formed
at 439 nm, indicating formation of WT-CN complex (Fig. 3.26, B). The isosbestic point at
427 nm is consistent with the presence of two species in the solution, uncomplexed WT
CPO and WT bound to cyanide. The Kd value calculated in this study, 130.0±6.5 μM, is
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close to the Kd reported previously for CPO-CN at pH 6.0, 95±10 µM (243). The difference
in values may arise from temperature variations during titrations and the fact that the
protein to ligand ratio was not high enough as required for calculations using Eq. 3.1.
However, addition of higher concentrations of the cyanide did not produce large enough
change in the spectrum of the WT that is needed for Kd determination. Thus, Kd result
here should be treated as an estimate.
When 1 mM CN- is added to the mutants, the intensity of the Soret peak decreases
and it red-shifts to 421 nm for R26A and N33A mutants (Figs. 3.27 and 3.28) and to 422
nm for R26A/N33A (Fig. 3.29). However, when CN- concentration is increased, the Soret
band moves to 422 nm, 425 nm, and 430 nm for R26A, N33A, and R26A/N33A,
respectively, while band intensities decrease further. The presence of the isosbestic point
in all mutant spectra is consistent with the equilibrium between uncomplexed CPO and
CPO-CN species. Higher CN- concentrations (mM range) required to observe spectral
changes indicate that cyanide has lower affinity for the mutants.

The data for Kd

determination is plotted in Fig. 3.30. Calculated Kd values for R26A, N33A, and
R26A/N33A are 3.6 mM, 10.5±1.0 mM, and 3.8±0.4 mM, respectively, which confirms
that CN- has lower affinity for the mutants. The Kd result for R26A mutant does not include
the standard deviation and should be treated with caution since only one trial was
performed because of the low yield of this mutant.
Previous studies on ligand binding to CPO revealed that cyanide diffuses into the
distal heme pocket in a protonated form, HCN, and loses its proton upon binding to the
heme iron (174, 220). Since WT CPO has no distal ligand, HCN can bind to the heme more
readily. In contrast, R26A, N33A, and R26A/N33A CPO have low-spin ferric heme and
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likely possess water or another amino acid as a distal ligand that competes with CN- for
binding to the heme, which would explain lower CN- affinity for the mutants.

Figure 3.26. Titration of WT CPO with cyanide in phosphate buffer, pH 6.0. A. 2-10
mM CN-. B. 10-800 µM CN-.
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Figure 3.27. Titration of R26A CPO with CN- (1-10 mM) in phosphate buffer, pH 6.0.

Figure 3.28. Titration of N33A CPO with CN- (1-10 mM) in phosphate buffer, pH 6.0.
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Figure 3.29. Titration of R26A/N33A with CN- (1-10 mM) in phosphate buffer, pH 6.0.

Figure 3.30. CN- Kd determination for the mutant CPO (Only 1 trial for R26A was
performed because of the limited amount of the protein, hence there are no error bars).
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The Hill plot (Fig. 3.31) (240) was used to explore the binding stoichiometry of CNto mutant CPOs. The slopes of all three graphs are very close to 1 confirming that
CN- binding to the R26A, N33A, and R26A/N33A mutants follows the same stoichiometry
as in binding to the WT: one molecule of cyanide binds to one molecule of CPO.

Figure 3.31. The Hill plot (determination of mutant CPO-CN binding stoichiometry). The
slopes of R26A, N33A, and R26A-N33A plots are 1.0048, 0.9943, and 1.0249,
respectively.
Cyanide (100 mM) binding was also performed at pH 12.0 to probe its ability to bind
to mutant CPO in deprotonated form (pKa 9.14). The WT spectrum at pH 12.0 is consistent
with the second alkaline transition occurring near pH 11.0, reported previously for CPO
(Fig. 3.32) (220). Alkaline transitions at pH 12.0 have been also observed in N33A and
R26A/N33A CPOs (Fig. 3.33 and 3.34). The CN- binding to R26A at alkaline pH has not
been performed because of the low yield of R26A. Spectral properties of CPO and cyanide
complexes are summarized in Table 3.4.
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Figure 3.32. Cyanide (100 mM) binding to WT CPO in phosphate buffer, pH 12.0.

Figure 3.33. Cyanide (100 mM) binding to N33A CPO in phosphate buffer, pH 12.0.
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Figure 3.34. Cyanide (100 mM) binding to R26A/N33A in phosphate buffer, pH 12.0.
When 100 mM CN- is added to the WT, N33A, and R26A/N33A, the spectra of all
three complexes look essentially the same, with the Soret band at 422 nm, and do not
change after 1-hour incubation suggesting that these cyanide derivatives are different from
those formed at pH 6.0. This result is expected since the native forms of the WT and
mutants at pH 12.0 are different from those at pH 6.0.
The mechanism of CN- binding at alkaline pH is more difficult to interpret since
several changes are occurring. First, HCN ionizes to CN- possibly making it more difficult
to diffuse into the active site and/or bind to the heme iron. Second, WT CPO undergoes an
alkaline transition that seems to differ from that in the mutants judging from the spectra at
pH 12.0. My results for CN- binding at alkaline pH are consistent with decreased
CN- affinity to the WT (Kd of 4 mM) reported at pH 9.5 (174). However, it should be noted
that the cyanide derivative of the WT CPO at pH 9.5 is different from that at pH 12.0 since
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its Soret peak is 15 nm red-shifted from that in the WT-CN complex at pH 12.0 (437 nm
vs. 422 nm), and the second alkaline transition in WT CPO takes place at pH 11, thus CNbinds to two different forms of CPO.
Table 3.4. UV-Vis spectral properties of ferric WT and mutant CPO and their cyanide
complexes at pH 6.0 and pH 12.0. (s), (n.s), and (s.s) denote the presence of a shoulder, no
shoulder, or a slight shoulder, respectively.
δ band
(nm)

Soret
(nm)

β band
(nm)

α band
(nm)

CT
(nm)

WT CPO (pH 6)

--

398

515

550

650

WT-CN (pH 6)

364

439

--

564

--

WT CPO (pH 12)

361

422

--

547

--

WT-CN (pH 12)

361

422

--

547

--

R26A (pH 6)

354

418
(s)

540

568

644

R26A-CN (pH 6)

364

436→432

--

560

--

N33A (pH 6)

356

420
(n.s)

540

575

--

N33A-CN (pH 6)

364

437→427

--

557

--

363 (as a
shoulder)

385

--

--

--

N33A-CN (pH 12)

363

422

--

547

--

R26A/N33A (pH 6)

356

421
(s.s)

540

575

644
(low)

R26A/N33A-CN (pH 6)

364

439→437

--

555

--

R26A/N33A (pH 12)

360

422

543

578

646

R26A/N33A-CN
12)

360

436→430

--

555

--

Protein

N33A (pH 12)

(pH

Interestingly, the spectrum of the WT after transition at pH 7.5 to the low-pin form is
similar to the spectra of the mutants at pH 6.0 that also possess a low-spin heme iron, and
the cyanide Kd values for these CPO forms are comparable (4 mM for the WT vs. 3.6 mM,
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3.8 mM, and 10.5 mM for the mutants). However, the WT and mutant low-spin forms must
be different since the low-spin WT is enzymatically inactive, while the mutants are active.
3.4 Conclusion
H-bonding networks within the active sites are conserved features in many heme
proteins. Such networks in the distal and proximal heme sides of peroxidases and
cytochrome P450s are important for their structure and catalysis. My study examined the
contributions of the H-bonding network formed by Arg 26-Asn 37 and Ala 27-Asn33 on
the proximal side of CPO to the structural and thus spectroscopic properties of the enzyme.
The R26A, N33A, and R26A/N33A CPO were characterized with various spectroscopic
techniques and compared to the WT.
My results have shown that removal of H-bonds in either of the residue pairs does not
significantly affect secondary structure. However, alpha-helical content is dramatically
increased if all H-bonds are removed. Additionally, all mutants exhibit differences in
tertiary CD, which indicates that the proximal H-bond network is important for maintaining
the tertiary structure of CPO, which in turn influences the environment of the active site.
Carbon monoxide and cyanide binding results have demonstrated that removal of H-bonds
in the proximal site of CPO induces structural changes that have a larger effect on binding
of anionic ligand than on binding of a neutral ligand.
It is likely that removal of the proximal H-bonds changes the flexibility of helix A,
affecting its position relative to the heme and influencing its interactions with the protein
matrix. The dislocation of the helix A is likely to change the bond length between the iron
and the proximal thiolate, which in turn would affect the heme environment and thus the
catalytic properties of CPO discussed in the next chapter.
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CHAPTER IV.
EFFECTS OF HYDROGEN BOND NETWORK IN THE PROXIMAL HELIX ON
CATALYTIC PROPERTIES OF CHLOROPEROXIDASE
4.1 Background
As mentioned in Chapter I, CPO is a heme-thiolate protein that belongs to the
peroxidase-peroxygenase family of enzymes (28, 71). Many heme enzymes are capable of
efficiently catalyzing one or two particular types of reactions, depending on the class of the
enzyme. However, CPO is capable of catalyzing a plethora of reactions such as
halogenation, peroxidation, peroxide dismutation, and epoxidation that are characteristic
of multiple enzyme classes (112, 113, 141, 142). The aforementioned reactions and other
oxidations are catalyzed by the reactive form of CPO, Cpd I, which is formed by binding
of hydrogen peroxide to the ferric resting state of the protein. The proximal oxygen of the
peroxide is deprotonated by Glu 183, producing the so called Compound 0 (Cpd 0),
followed by an initial homolytic O-O bond scission. The homolytic process becomes
heterolytic as the proton which was removed from the proximal oxygen, is transferred to
the distal oxygen, and a water moiety departs, producing the oxo-ferryl cationic-radical
intermediate, Cpd I (106, 226).
The formation rates and reactivity of Cpd I depend on the pKa of the distal ligand and
electron-donating ability of the proximal ligand (204, 244). The higher basicity of the distal
ligand (H 2 O 2 ) would result in slower formation of Cpd 0 since proton removal from
peroxide-bound ferric heme would be more difficult. However, if the pKa is too low it
would result in slower formation of Cpd I from Cpd 0 because of the difficulty in
protonating Cpd 0. Additionally, the electronegativity of the proximal thiolate creates a so-
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called ‘push effect’ that directly influences distal ligand pKa and Cpd I redox potential
(234, 244-246). The ‘push’ provided by the proximal thiolate increases the basicity of the
distal oxygen in Cpd 0, thus facilitating water release and Cpd I formation. However, the
‘push’ concurrently decreases the redox potential and thus the reactivity of Cpd I. To
modulate the ‘push’ for the optimal activity without preventing formation of Cpd 0, CPO
and other heme thiolate enzymes evolved mechanisms for reducing thiolate
electronegativity via Cys-amide H-bonds and the electropositive environment of the Nterminus of the proximal helix (244).
Hydrogen bonding between a proximal Cys and polypeptide amides is a common
feature of many heme thiolate proteins including CPO, P450s, and NO synthase (71, 98,
247). In CPO, Cys 29 is H-bonded to the peptide NH groups of Ala 31 and Leu 32 situated
at the N-terminus of helix A, while in P450cam the proximal Cys 357 is H-bonded to NH
groups of Leu 358, Gly 359, and Gln 360 (71, 98). These H-bonds contribute to the
increase of the iron redox potential by decreasing the negative charge on the Cys ligand,
and stabilize the thiolate by preventing its protonation and protecting against diatomic
reactants, all of which result in the formation of inactive forms of the enzyme (101, 102).
As demonstrated by mutation studies on P450cam by Yoshioka et al., removal of thiolateamide bonds in L358P, Q360P, and Q360L mutants results in increased push effect and
reduced redox potential of the enzyme (101, 211).
Once Cpd I is formed in CPO, it is able to follow different catalytic pathways. For
example, Cpd I can either form oxo-ferryl (possibly, hydroxy-ferryl) Cpd II in the
peroxidation pathway, oxo-ferric Cpd X in halogenation pathway, or return to its resting
state via dismutation and P450 pathways (104, 107, 109). One-electron oxidations that
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occur via the peroxidation pathway include peroxidation and oxidative de-halogenation
reactions and have been proposed to occur on the surface of the enzyme (112, 127, 137,
138). Although Cpd II, an intermediate formed during one-electron oxidations, is
postulated to be an oxo-ferryl species, its protonation state is still debated. Computational
studies (107, 108) have suggested the iron(IV)-hydroxide species to be the major form of
Cpd II; however, this hypothesis has not been confirmed experimentally. Two-electron
oxidations include a variety of reactions such as halogenation, epoxidation, sulfoxidation,
peroxide dismutation, and are suggested to occur at the active site of CPO, except for
halogenations (112, 113, 141, 142). Compound X, ferric Fe-HOCl, is formed during
chlorination reactions catalyzed by CPO (109). No intermediates besides Cpd I have been
identified in other two-electron oxidations. The ability of CPO to catalyze such diverse
reactions is postulated to be a result of its unique active site structure.
Chloroperoxidase is folded into N- and C-terminal domains with the heme group
located between the domains. The active site of CPO is a peroxidase-P450 hybrid with a
peroxidase-like polar distal environment and a P450-like proximal thiolate ligation (71).
The proximal heme ligand, Cys 29, is located in the N-terminus of helix A, which is almost
perpendicular to the heme plane (71). Interestingly, in cytochromes P450 and most other
peroxidases with the imidazolate ligation, the helix containing the proximal ligand is
situated in the C-terminal domain and is parallel to heme (98). The electropositive helix
environment reduces the electronegativity of the proximal Cys, thus contributing to the
increase in redox potential, and has been termed the ‘proximal helix effect’. The almost
perpendicular orientation of the proximal helix to the heme in CPO provides a larger
increase in redox potential than observed in P450 with its parallel helix (99, 100, 248).
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Thus, Cys-amide H-bonds together with the proximal helix dipole have a significant
influence on the reactivity of CPO.
Hydrogen bond networks are important structural features in heme imidazolate
enzymes as well. In many peroxidases, the distal His-Arg pair is essential for efficient
production of Cpd I (64-66). In CPO, the role of the His-Arg pair is carried out by Glu 183
H-bonded to His 105. Both Arg in peroxidases and His in CPO provide a particular
orientation to the catalytic His and Glu, respectively, and aid in achieving optimal rates of
Cpd I formation (202, 249, 250). Proximal H-bond networks consisting of His-AspTrp/Phe and His-Asn-Arg are conserved in peroxidases-catalases and peroxidasescyclooxygenases, respectively. These networks are believed to stabilize higher oxidation
states of Cpd I and Cpd II by de-protonating the proximal His at Nδ position and
maintaining shorter Fe-imidazolate bond distances in peroxidases as compared to globins
that lack such a network (251, 252).
There are several amino acids in the proximal helix of CPO that also form a H-bonding
network, in particular Arg 26-Asn 37 and Ala 27-Asn 33. It is reasonable to suggest that
this H-bond network provides structural support for the proximal helix and helps its
positioning in a particular orientation relative to the heme, possibly influencing the
catalytic properties of the enzyme. However, no research has been done on the role of this
proximal H-bond network in defining the biochemical properties of CPO.
In this study, I investigated how deletion of H-bonds between Arg 26-Asn 37 and Ala
27-Asn 33 affect catalytic properties of CPO. I replaced Arg 26 and Asn 33 with Ala to
disrupt H-bonding and characterized R26A, N33A, and R26A/N33A CPO using various
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enzymatic assays and UV-Vis spectrophotometry. My results show that the H-bonding
network of the proximal helix is important for maintaining the catalytic diversity of CPO.
4.2 Experimental procedures
All the chemicals and materials used are described in section 2.2.1.
4.2.1 Construction of R26A, N33A, and R26A/N33A CPO mutants
To investigate the role of the hydrogen bond network in the proximal helix of CPO
(Arg 26-Asn 37 and Ala 27-Asn 33) in catalysis, R26A, N33A, R26A/N33A mutants were
constructed. Gene construction, expression, and purification of the mutants were
performed as described in sections 3.2.1 and 3.2.2.
4.2.3 Enzymatic assays
To investigate catalytic properties of the mutants lacking hydrogen bonds in the
proximal helix, enzymatic assays described in section 2.2.7 were performed with the
following modifications. Enzyme amounts used for the ABTS assay at various pH are listed
in Table 4.1.
Table 4.1. Enzyme amounts used in ABTS assay at different pH.
pH

WT (µM)

Mutant (µM)

2.75, 3.0

0.03

0.03

3.5

0.1

0.03

4.0, 4.5

0.5

0.03

5.0, 5.5

2.0

0.1

6.0

5.0

0.2

Styrene epoxidation assay (15) was performed in 100 mM phosphate-citrate or
phosphate buffer (pH 2.75, 3.0, 3.5, 4.0, 4.5, 5.0, 5.5, 6.0, 7.0, 8.0). Protein concentration
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was 0.3 µM. MCD assay was performed in 100 mM phosphate-citrate or phosphate buffer
(pH 2.75, 3.0, 3.5, 4.0, 4.5, 5.0). Protein concentration was 0.6 µM. Finally, dismutation
assay was performed in 100 mM phosphate-citrate or phosphate buffer (pH 2.4, 3.0, 3.5,
4.0, 4.5, 5.0, 5.5, 6.0). Protein concentration was 0.5 µM.
4.3 Results and discussion
In general, catalytic properties of heme proteins are influenced by the heme iron redox
potential, architecture of the active site, and electrostatic interactions present in the distal
and proximal sides (48, 106, 207, 244). To examine the effect of the proximal hydrogen
bonding on catalytic properties of CPO, chlorination (MCD), dismutation (H 2 O 2 ),
peroxidation (ABTS), and epoxidation (styrene) assays were performed.
4.3.1 Chlorination and dismutation activities of WT and mutant CPO at various pH
The chlorination reaction catalyzed by WT CPO is most efficient at very acidic pH
with highest rates at pH 2.75. Chlorination proceeds via one two-electron step with the
formation of Cpd I and Cpd X (109, 141). Thus, the rate of chloride oxidation depends on
the formation rates of the two intermediates. Since the rate of Cpd I formation has been
shown to be independent of pH (104, 106), Cpd X must be responsible for differences in
activities observed at various pH. Indeed, it has been demonstrated that only protonated
Cpd X is able to chlorinate MCD (109), which explains WT’s high chlorination activity at
acidic pH. In contrast, the mutant CPOs (R26A, N33A, and R26A/N33A) lacking H-bonds
in the heme proximal helix almost completely abolish chlorination activity at all pH values
checked (2.4-5.0, Figs. 4.1-4.2). The loss of chlorination activity may be explained by the
decrease in the Cpd I redox potential that is affected by the ‘push’, spin state, and the extent
of heme burial.
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Figure 4.1. pH profiles of WT and mutant CPO chlorination activities (some error bars are
smaller than the point size and are not visible on the graph).

Figure 4.2. pH profiles of R26A, N33A, and R26A/N33A CPO chlorination activities
(some error bars are smaller than the point size and are not visible on the graph).
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Figure 4.3. pH profiles of WT, R26A, N33A, and R26A/N33A CPO dismutation activities
(some error bars are smaller than the point size and are not visible on the graph).
Since disruption of the H-bond network in the heme proximal helix affects tertiary
structures of the mutants, it is likely that perturbations in the active site cause increase in
the electron push from the thiolate ligand, which in turn decreases redox potential. For
example, removal of the H-bonds may affect the positioning of the proximal helix, whose
dipole contributes to the thiolate ‘push’ decrease. Changes in helix A orientation may result
in a smaller electron density withdrawal from the heme that would reduce the redox
potential.
In P450s with a parallel position of the proximal helix relative to the heme, the helix
dipole results in only a 70 mV redox potential increase of Fe(III)/Fe(II) couple as opposed
to 130 mV in CPO whose proximal helix is perpendicular to the heme (204). In addition,
since the proximal helix of CPO contains Cys 29 ligated to the heme, changes in the
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position of the helix may affect the orientation of the proximal thiolate, which in turn can
affect the heme environment.
Tertiary structural changes, observed by CD, could have affected the heme exposure
to the solvent, which would also contribute to the decrease of both the redox potential and
catalatic activity of the enzyme (253, 254). This is consistent with negligible dismutation
activity of the mutants (Fig. 4.3).
Hydrogen peroxide decomposition, a two-electron oxidation reaction, is catalyzed by
WT CPO most efficiently at acidic pH with the highest rates at pH 4.5-5.0. N33A and
R26A/N33A do not have any dismutation activity in the acidic pH range, while R26A
mutant has a very low activity at pH 4.5-5.0. The low catalatic activity of R26A indicates
that it might have a slightly higher redox potential than the other two mutants, which would
allow peroxide dismutation though not be high enough for chloride oxidation.
4.3.2 Peroxidation and epoxidation activities of WT and mutant CPO at various pH
The optimal pH range for ABTS peroxidation by the WT CPO is 2.75-3.0. The activity
of WT CPO is decreased more than 10-folds at pH 3.5, and peroxidation is negligible at
pH above 4.0. In contrast, R26A and N33A possess significantly higher peroxidation
ability in pH range 3.5-5.0 with the optimal activity at pH 3.5 while R26A/N33A is more
active at all pH checked (Fig. 4.4). The peroxidation activity of the double mutant is about
2-fold higher than that of R26A and N33A at pH 3.5.
The shift in optimal pH for peroxidation activity can be explained by the possible
increase in the pKa of Cpd II. High activity of the WT below pH 3.5 suggests that
protonation of Cpd II might be required for the peroxidation reaction to occur, similarly to
the protonation of Cpd X in the halogenation pathway, and that Cpd II has a low pKa
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(below 3.5). In mutant CPOs, the pKa of Cpd II might be higher, and that would result in
the formation of the active protonated Cpd II at higher pH. Hence, peroxidation is able to
occur over a wider pH range. This observation is also consistent with the proposed inverse
relation of the heme redox potential and pKa of the distal ligand. The lower redox potential
of mutant CPOs that can be inferred from their inability to oxidize chloride would increase
the pKa of the distal ligand.

Figure 4.4. pH profiles of WT and mutant CPO peroxidation activities (some error bars
are smaller than the point size and are not visible on the graph).
Epoxidation of styrene, catalyzed by mutant CPOs, occurs at significantly higher rates
as compared to the WT. Wild-type CPO oxidizes styrene over a wide pH range, 2.75-7.0
(Fig. 4.5). A significant decrease in activity is observed at pH higher than 7.0 because of
the formation of the inactive alkaline species of CPO. The rates of styrene epoxidation do
not seem to heavily depend on pH since the difference between specific activities, for
example, at pH 6.0 and 2.4 is only 2-fold. A similar situation is observed in epoxidations
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catalyzed by the mutants, which are active in the pH range 2.4-9.0 with specific activities
varying only about 1.5-fold (Fig. 4.5). This observation indicates that epoxidation does not
require a catalytic intermediate, whose protonation state determines the reaction rates, as
has been observed in chlorination and peroxidation assays. Also, it should be noted that in
the case of mutant CPOs, the enzymes remain very active at pH 9.0, suggesting that mutant
CPOs do not form the inactive alkaline form similarly to WT CPO. This result is also
confirmed by electronic absorption spectra of the mutants showing that native enzyme
forms start changing only at pH 10.0.

Figure 4.5. pH profiles of WT and R26A CPO epoxidation activity (some error bars are
smaller than the point size and are not visible on the graph).
In mutant CPOs, the lack of catalatic activity, which competes with other reactions
for Cpd I, is expected to contribute to the increase in peroxidation and epoxidation rates.
During hydrogen peroxide decomposition, a molecule of hydrogen peroxide binds the
ferric enzyme, and Cpd I is formed. Next, another molecule of hydrogen peroxide binds to
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Cpd I. Hydrogen peroxide is decomposed into water and oxygen while Cpd I is converted
back to the ferric resting state. This process results in premature depletion of the oxidizing
agent necessary for the formation of Cpd I, which is required for peroxidation and
epoxidation. When dismutation is absent, more Cpd I is available in the reaction and
hydrogen peroxide is not depleted via the dismutation pathway.
As judged from tertiary CD (chapter 3), another possible contribution to the increase
in epoxidation activity of the mutants is the changes in accessibility of the active site by
substrates, which is important for two-electron oxidations by heme enzymes (237). Large
changes in the secondary structure of the double mutant, having the highest epoxidation
rates, are consistent with this hypothesis.
4.3.3 Comparison of WT and mutant CPO activities at optimal pH
pH 2.75 and pH 4.5 were chosen to compare specific activities of WT and the mutants
since

these

are

the

optimal

pH

values

for

chlorination/peroxidation

and

epoxidation/dismutation activities, respectively. Furthermore, the majority of specific
activities of the WT and other mutant CPOs reported in the literature were measured at pH
2.75 (chlorination) and pH 4.5 (dismutation, peroxidation, epoxidation). Hence, my results
for mutant activities can be compared to the activities of other CPO mutants.
At pH 2.75, R26A and N33A possess about 60% peroxidation activity of that of the
WT (Fig. 4.6). However, at pH 4.5, R26A and N33A showed around 80-fold and 70-fold
increase in peroxidation activity, respectively (Fig. 4.7). The double mutant, R26A/N33A,
is more active than the WT at both pH 2.75 and 4.5, showing 1.3-fold and an astounding
250-fold increase in peroxidation, respectively (Figs. 4.6-4.7). All mutants are more active
in epoxidation assay as well, showing 3.5-fold, 2.8-fold, and 7.2-fold increase (R26A,
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N33A, and R26A/N33A, respectively) (Fig. 4.8). Different trends are observed in
chlorination and dismutation assays.

Figure 4.6. Relative peroxidation activities of the WT and mutant CPOs at pH 2.75.

Figure 4.7. Relative peroxidation activities of the WT and mutant CPOs at pH 4.5.
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Figure 4.8. Relative epoxidation activities of the WT and mutant CPOs at pH 4.5.

Figure 4.9. Relative dismutation activities of the WT and mutant CPOs at pH 4.5.
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Figure 4.10. Relative chlorination activities of the WT and mutant CPOs at pH 2.75.
R26A shows a slight dismutation activity (5% of that of the WT) (Fig. 4.9). All
mutants possess negligible chlorination activity (Fig. 4.10). These results suggest that the
redox potentials of R26A, N33A, and R26A/N33A mutants might be lower than that of the
WT.
Overall, my results indicate that H-bond network in the proximal helix A of CPO
plays an important role in maintaining the secondary and tertiary structures of CPO and
contributes to its high chlorination and dismutation activities. However, the presence of
these H-bonds also results in decreased epoxidation and peroxidation rates, especially at
slightly acidic and neutral pH.
4.4 Conclusion
There has been quite a substantial amount of work published on heme protein catalysis
over the years. It is clear that heme proteins evolved multiple mechanisms that work
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together to carry out their particular biological functions. Many factors that influence
catalytic properties of heme enzymes have been identified including types of electronic
structures, nature of heme ligands, electrostatic interactions, and H-bond networks.
However, the importance and particular contributions of many structural features in
catalysis remain to be delineated. No research has been published on the role of the H-bond
network in the proximal helix of CPO on its catalysis. In this work, I employed rational
design to investigate the role of this H-bond network in the catalytic properties of CPO.
Three CPO mutants (R26A, N33A, and R26A/N33A) were engineered and characterized
using various enzymatic assays. My results have shown that the proximal H-bond network
is as important for the catalytic diversity of CPO as the proximal thiolate ligand, and is also
responsible for providing CPO with its high chlorination and dismutation activities. My
research contributes to the ongoing exploration of factors that influence heme catalysis and
helps us better understand the structure-function relations in heme-thiolate proteins in
general and in CPO in particular.
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CHAPTER V.
PERSPECTIVES
The results of this work show that several structural features of the proximal heme
pocket, particularly the axial thiolate and H-bond network, strongly influence the ligandbinding and catalytic properties of CPO. Although C29, R26, and N33 in the proximal site
do not directly participate in catalysis, they influence the structure of the protein and the
heme environment, which in turn significantly affect the catalytic behavior of CPO.
The CPO mutants investigated in this work (C29H, R26A, N33A, and R26A/N33A)
can be further studied by RR and NMR spectroscopies to obtain more information about
the structure of the active site. Solving crystal structures of the mutants would help better
understand ligand-binding and catalysis results. The ligand-binding properties of mutant
CPO can be further investigated with thiocyanate, nitric oxide, halides, etc. to gain insights
into factors affecting ligand binding. Catalytic behavior can be further explored with other
reactions such as sulfoxidation, hydroxylation, bromination together with various
substrates. The enantioselectivity of oxygen insertions would present an attractive target
for the pharmaceutical and chemical industries. Investigations of CPO with other point
mutations in the active site or disulfide bond region would be also interesting.
Mutant CPO production requires large amounts of media because of much lower
protein yields as compared to the WT. Hence, determination of factors influencing the
expression of CPO mutants and their secretion in the holo form, and optimization of fungal
expression systems would help increase mutant CPO yields, encouraging further research
on CPO and other heme proteins, especially those ones that are understudied because of
the difficulties associated with obtaining good yields.
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APPENDIX
Figure A1. Primers used for construction of C29H/C79H and C29H/C79H/C87H CPO
(His mutation is shown in bold).

Coding strain - C29H/C79H primer 1 (C29H pCPO was used as a template)
5’- GTCGTCCACGAGTACGTTACTGGCTCCGACTGTGGTGACAGC - 3’
Non-coding strain – C29H/C79H primer 2
5’- AGCCAGTAACGTACTCGTGGACGACGAAGGTGTTGTCAGAGC - 3’

Coding strain - C29H/C79H/C87H primer 1 (C29H/C79H pCPO was used as a template)
5’- CTCCGACCATGGTGACAGCCTTGTCAACCTGACTC - 3’
Non-coding strain – C29H/C79H/C87H primer 2
5’- GTCACCATGGTCGGAGCCAGTAACGTACTCGTG - 3’

Figure A2. Nucleotide sequence of full-length WT CPO gene.

ATGTTCTCCAAGGTCCTTCCCTTCGTGGGAGCGGTTGCCGCCCTCCCTCACTC
CGTCCGTCAGGAGCCTGGCTCCGGCATTGGCTACCCATACGACAACAACACC
CTGCCATATGTCGCCCCAGGTCCTACCGACTCTCGTGCTCCTTGCCCAGCTCT
GAACGCTCTTGCCAACCACGGTTACATTCCTCACGATGGCCGTGCCATCAGC
AGGGAGACCCTCCAGAACGCTTTCCTCAACCACATGGGTATTGCCAACTCCG
TCATTGAGCTTGCTCTGACCAACGCCTTCGTCGTCTGCGAGTACGTTACTGGC
TCCGACTGTGGTGACAGCCTTGTCAACCTGACTCTGCTCGCCGAGCCCCACGC
TTTCGAGCACGACCACTCCTTCTCCCGCAAGGATTACAAGCAGGGTGTCGCC
AACTCCAACGACTTCATCGACAACAGGAACTTCGATGCCGAGACCTTCCAGA
CCTCTCTGGATGTCGTTGCAGGCAAGACCCACTTCGACTATGCCGACATGAA
CGAGATCCGCCTTCAGCGCGAGTCCCTCTCCAACGAGCTTGACTTCCCCGGTT
GGTTCACCGAGTCCAAGCCAATCCAGAACGTCGAGTCTGGCTTCATCTTCGCC
CTTGTCTCTGACTTCAACCTGCCCGACAACGATGAGAACCCTCTGGTTCGCAT
TGACTGGTGGAAGTACTGGTTCACCAACGAGTCCTTCCCATACCACCTCGGCT
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GGCACCCCCCGTCTCCAGCCAGGGAGATCGAGTTCGTCACCTCCGCCTCCTCC
GCTGTCCTGGCTGCCTCTGTCACCTCTACTCCATCTTCCCTTCCATCCGGTGCC
ATCGGCCCAGGTGCCGAGGCTGTCCCTCTCTCCTTCGCCTCCACCATGACCCC
ATTCCTCCTCGCCACCAATGCTCCTTACTACGCCCAGGACCCAACTCTCGGCC
CCAACGACAAGCGTGAGGCTGCCCCAGCTGCCACCACCTCCATGGCCGTCTT
CAAGAACCCATACCTCGAGGCCATTGGCACCCAGGACATCAAGAACCAGCA
GGCTTACGTCAGCTCCAAGGCTGCTGCCATGGCCTCTGCCATGGCCGCCAAC
AAGGCCCGCAACCTTTAA

Figure A3. Amino acid sequence of WT CPO including signal peptide (1-20) and
propeptide (322-373).
1

MFSKVLPFVG AVAALPHSVR QEPGSGIGYP YDNNTLPYVA PGPTDSRAPC

51 PALNALANHG YIPHDGRAIS RETLQNAFLN HMGIANSVIE LALTNAFVVC
101 EYVTGSDCGD SLVNLTLLAE PHAFEHDHSF SRKDYKQGVA NSNDFIDNRN
151 FDAETFQTSL DVVAGKTHFD YADMNEIRLQ RESLSNELDF PGWFTESKPI
201 QNVESGFIFA LVSDFNLPDN DENPLVRIDW WKYWFTNESF PYHLGWHPPS
251 PAREIEFVTS ASSAVLAASV TSTPSSLPSG AIGPGAEAVP LSFASTMTPF 301
LLATNAPYYA QDPTLGPNDK REAAPAATTS MAVFKNPYLE AIGTQDIKNQ
351 QAYVSSKAAA MASAMAANKA RNL
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